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ABSTRACT
An estimated 25 billion in US health care expenditure is spent on care of chronic,
non-healing wounds. The failure to effectively heal wounds is often compounded by comorbidities, such as diabetes or obesity. Another major patient population afflicted with
chronic wounds are the elderly. Advanced age is associated with a decline in
immunologic function that contributes to a poor response to vaccination, infection and
tissue injury resulting in prolonged hospital stays and age-related morbidity and
mortality. Specifically, clinical observations and laboratory studies have suggested an
age-related decline in cutaneous wound healing, marked by protracted wound closure,
wound dehiscence and chronic wound states.
Previous studies have suggested that age-related alterations in the early inflammatory
phase of cutaneous wound injury may contribute to the lengthened and aberrant course of
wound healing in the elderly. This impaired response to cutaneous injury offers a
persistent portal of entry for foreign pathogens, such as Staphylococcus aureus (S.
aureus), a common dermatopathogen that accounts for up to 50% of surgical site
infections in the elderly. Underlying this elevated susceptibility to infection are deficits in
host recognition, phagocytosis, migration and activation of a pathogen-specific adaptive
immune response. Specific innate immune deficits have been tied to an elevated risk of S.
aureus wound infection, including decreased neutrophil counts and function, reduced
expression of cutaneous antimicrobial peptides and aberrant toll-like receptor 2 (TLR2)
xiii

expression and/or signaling. However, the effect of age on these specific alterations in
the innate response has not been well described in a model of cutaneous wound infection.
Thus, we hypothesized that advanced age contributes to a functionally inept innate
immune response that impairs resolution of S. aureus cutaneous wound infection.
To elucidate the effects of advanced age on cutaneous wound infection, the specific
aims were (i) To establish a model of local cutaneous wound infection in young and aged
mice, (ii) To determine if age-related changes in leukocyte phagocytosis, leukocyte
recruitment or cutaneous antimicrobial peptide expression contribute to age-associated
differences in bacterial colonization and wound closure (iii)To determine if modulation
of these age-associated deficits in the early innate response to S. aureus cutaneous wound
infection may provide new therapeutic avenues for treating wound infection and
promoting wound closure in the elderly.
Aim 1 was to establish of model of cutaneous injury and S. aureus infection in young
(3-4 month) and aged (18-20 month) BALB/c mice. Following injury and infection at
days 1-10, we observed heightened bacterial colonization and delayed wound closure in
aged animals as compared to young.
In Aim 2, we utilized this model to evaluate keratinocyte and resident leukocyte TLR
expression, leukocyte infiltration and phagocytosis and wound antimicrobial peptide
expression. While no differences in infiltrating leukocyte TLR expression, phagocytosis
or antimicrobial peptide expression were noted, decreased neutrophil and macrophage
recruitment to the wound site were observed in aged mice relative to young. In an in vivo
xiv

chemotaxis assay, we confirmed a reduced migratory capacity to increasing doses of the
neutrophil chemokine KC in aged mice.
Given these findings, we sought to modulate neutrophil recruitment to the wound site in
Aim 3. Following cutaneous injury and infection, mice either received 3 s.c. injections of
250 pg of G-CSF or saline vehicle. G-CSF treatment in aged mice reduced bacterial
colonization and wound size relative to saline controls. This was associated with
increased neutrophil accumulation in wounds of aged, G-CSF treated mice at days 3 and
7 following injury and infection. While future work needs to be conducted to elucidate
the mechanism by which G-CSF exerts these age-dependent effects, our data highlights a
putative indication for G-CSF treatment within the wound care setting in the elderly
patient population as well as patients with local or systemic neutropenia.
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CHAPTER 1
INTRODUCTION
Advanced age is associated with a decline in immunologic function that
contributes to a poor response to vaccination, infection and tissue injury resulting in
prolonged hospital stays and age-related morbidity and mortality. Specifically, clinical
observations and laboratory studies have reported an age-related decline in cutaneous
wound healing, marked by protracted wound closure, wound dehiscence and chronic
wound states. Previous studies have suggested that age-related alterations in the early
inflammatory phase of cutaneous wound injury may contribute to the lengthened and
aberrant course of wound healing in the elderly. This impaired response to cutaneous
injury offers a persistent portal of entry for foreign pathogens, such as Staphylococcus
aureus (S. aureus), a common dermatopathogen that accounts for up to 50% of surgical
site infections in the elderly. Specific innate immune deficits have been tied to an
elevated risk of S. aureus wound infection, including decreased neutrophil counts and
function, reduced expression of cutaneous antimicrobial peptides and aberrant Toll-like
receptor (TLR) 2 expression and/or signaling. However, the effect of age on these
specific alterations in the innate response has not been well described in a model of
cutaneous wound infection. Thus, we hypothesize that advanced age contributes to a
functionally inept innate immune response that increases the susceptibility to cutaneous
wound infection with S. aureus. To elucidate the effects of advanced age on cutaneous
1
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wound infection, the specific aims of this proposal are (i) To establish a model of local
cutaneous wound infection in young and aged mice, (ii) To determine if age-related
changes in leukocyte phagocytosis, leukocyte recruitment or cutaneous antimicrobial
expression contributes to age-associated differences in bacterial colonization and wound
closure (iii)To determine if modulation of these age-associated deficits in the early innate
response can enhance resolution of S. aureus wound infection in aged animals. Overall,
this project will potentially reveal age-specific alterations in the innate immune response
to cutaneous wound infection that may provide novel treatment options, ultimately
improving clinical outcomes in the elderly.

Hypothesis: Impaired function of innate immune leukocytes and cutaneous antimicrobial
peptides delays resolution of cutaneous wound infection with advanced age.

Aim 1: To establish a model of cutaneous S. aureus wound infection in young and aged
mice.
Aim 2: To determine age-related alterations in innate immunity that may contribute to
differences in bacterial colonization and wound closure with advance age.
Subaim 2A: To determine if an age-related impairment of phagocytosis and/or
bactericidal activity promotes delayed resolution of wound infection
in aged mice.
Subaim 2B: To evaluate leukocyte recruitment and factors involved in leukocyte
infiltration that may contribute to differences in bacterial burden and
wound closure in aged mice.
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Subaim 2C: To examine if age-associated differences in cutaneous antimicrobial
peptide expression contribute to heightened bacterial colonization and
reduced wound healing in aged mice.
Aim 3: To determine if local, subcutaneous treatment with granulocyte-colony
stimulating factor (G-CSF) can enhance resolution of cutaneous wound infection
in aged mice.

CHAPTER 2
REVIEW OF RELATED LITERATURE
Aging, life expectancy and healthy living years
Health care advancements have contributed to a constant, linear increase in the
expected lifespan in developed countries. In 1950, the probability of survival to 80-90
years of age was 12-16% and had doubled to 25-37% by 2002 (1). Interestingly, life
expectancy data from the last century suggests that we have yet to reach the limits of
human longevity (1), supporting the concept that the proportion of our population
considered elderly, or over 65, will increasingly comprise a greater percentage of our
population as a whole. Despite advances in health care that have improved human
lifespan, our healthy living years are still limited by diseases that compromise activities
of daily living and cognition. It has been reported that disease prevalence has grown in
the aging population over time (1). While improved detection may account from some of
the increase in disease prevalence, diabetes, obesity, cancer and heart disease have all
risen markedly in the elderly. Of note, a dichotomy in the aging population is observed.
Some individuals are able to maintain daily living activities, ward off infection and do
not develop severe autoimmune or malignant conditions. Another sub-population, often
referred to as the “frail” elderly, lose the ability to maintain clinical measures of
independent living (i.e. management of medication, transportation, preparation of meal,
etc.) and their physical deterioration is often marked by infection and significant
pathology (1, 2). Given the seemingly unimpeded growth of the aging population, efforts
to reduce chronic disease and improve healthy living years will greatly improve quality
of life measures and curb the predictable strain on already unstable medical care systems.
4

5

A better understanding of the mechanisms that play a role in healthy and frail aging are
critical to expanding healthy living years in the elderly and may help stifle a growing
public health predicament.

Aging and Innate Immunity
A predominate contributing factor to these clinical ailments is dysfunction of the
immune system. In particular, dysregulation of the innate immune response contributes
directly to aging pathologies, as well as indirectly by altering activation of the adaptive
arm of the immune response. In aged individuals, there is a paradoxical activation of
baseline inflammation referred to as “inflamm-aging” coupled with a refractory response
to immune challenge known as “immunosenescence” (reviewed in (3-6)). With advanced
age, the inability to balance pro- and anti-inflammatory responses generates a basal
elevation in pro-inflammatory mediators that may blunt appropriate innate and adaptive
cellular immune activation and function (Figure 1). This disrupted balance between
inflammation and immune activation may contribute to a variety of co-morbidities and
increased mortality following both local and systemic insults (7-11). Herein, we discuss
how aging negatively impact the host immune response and clinical outcomes by
impairing three innate immune mediators: antimicrobial peptides, neutrophils and
macrophages.
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Young Adult

Elderly

Increasing Age
Inflamm-aging
IL-6, TNF-a
Stress Hormones

Immunosenescence
Innate Immune Response:
Pathogen recognition, chemotaxis, phagocytosis

Adaptive Immune Response:
Naïve T cell number, cytotoxicity, antibody quality and quantity

Morbidity and Mortality

Figure 1. The skewed balance of the aging innate immune system. Advanced aged is
marked by a heightened, basal pro-inflammatory response termed “inflamm-aging” that it
built upon genetic, epigenetic and hormonal age-associated changes. Additionally,
following antigenic challenge or systemic insult, immune cells from the elderly
demonstrate an immunosenescent phenotype. Together, this results in greater morbidity
and mortality following trauma or infection. Modified from (12).
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Antimicrobial Peptides
Antimicrobial peptides (AMPs), such as defensins and cathelicidins, are small
cationic molecules that are able to promote bacterial killing via interactions with the
bacterial membrane, leading to membrane destabilization and bacterial lysis (13, 14).
Several families of AMPs have been identified, including -defensins, -defensins,
cathelicidins and the Reg family of AMPs. Over the past few years, these small
molecules have garnered increasing attention for their bactericidal properties and
modulation of wound healing (15-18). In addition to their bactericidal potential, AMPs
are also known to be directly chemotatic for neutrophil and macrophages, highlighting
their importance in regulation of the innate immune response (13, 19). However, very
little has been published regarding the impact of advanced age on this innate immune
subset. One study has reported that cathelicidin related antimicrobial peptide (CRAMP)
mRNA expression was 10-100 fold higher in skin from neonatal mice as compared to
adult mice, however aged animals were not examined (20). In another study,
immunostaining for CRAMP and mouse -defensin 3 (mBD3) in intact epidermis
revealed reduced CRAMP levels in epidermal cells from 15-18 month aged mice as
compared to young animals (21). However, levels of mBD3 in these aged animals were
increased relative to young controls (21). Given the important immunomodulatory and
host defense properties of these small molecules, further work to evaluate how they are
impacted by age is warranted.
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Neutrophils
Alongside AMPs, neutrophils are a critical first line of defense for the innate arm
of the immune system in response to infectious challenge. Swift recruitment and
activation of neutrophils occurs via integration of several, successive signaling steps
involving selectins, integrins, chemokines and G protein coupled receptors (22, 23). The
primary chemotatic signals for neutrophils in mice are KC and macrophage inflammatory
protein-2 (MIP-2), both human interleukin (IL) -8 functional homologs. Other signals
included complement factor C5a and leukotriene B4. KC and MIP-2 interact with the
neutrophil chemoattractant receptor CXCR2 to initiate intracellular signaling pathways
involved in neutrophil chemotaxis (24, 25). Specifically, downstream of CXCR2,
activation of the small GTPase Ras-related protein 1 (Rap1) has been show to be crucial
in mediating adhesion by regulation of two integrins, lymphocyte-function associated
antigen-1 (LFA-1: CD11a/CD18) and very late antigen-4 (VLA-4: CD49a/CD29; 26-28).
Rap1-induction of integrin activity occurs via several convergent pathways downstream
of CXCR2; however, the canonical pathway involves activation of phospholipase C
(PLC; (26, 27, 29, 30). This upregulation of selectins and integrins promotes loose rolling
followed by firm adhesion mediated by interactions with intracellular adhesion molecule1 (ICAM-1) and vascular cellular adhesion molecule-1 (VCAM-1) present on activated
endothelium. Firm adhesion coupled with apically suspended chemokines promotes
neutrophil diapedesis to the site of injury or infection (Figure 2).
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Cutaneous Wound Infection

Epidermis
Resident Immune Cells
and Keratinocytes
KC
MIP-2
MIP-2

KC
MIP-2

KC

Selectins

Dermal Matrix/
Subcutaneous Tissue

Site of Infection
CXCR2

ICAM-1

VCAM-1

3. Diapedisis

1. Rolling
ESL-1/PLG-1

VLA-4
LFA-1

2. Adhesion

Capillary Lumen

Figure 2. Neutrophil chemotaxis. Following cutaneous injury and infection, resident
immune cells and keratinocytes release a host of soluble factors to initiate the innate
immune response. In mice, release of the chemokines KC and MIP-2 act to recruit
neutrophils by diffusing across endothelial cells to interact with their chemokine receptor,
CXCR2, on peripheral blood neutrophils. Ligation of CXCR2 results in activation of PLC
and Rap-1 to promote upregulation and clustering of selectins and integrins that help
mediate (1) loose rolling followed by (2) firm adhesion via interaction with ICAM-1 and
VCAM-1 on activated endothelium. In response to apically suspended chemokines,
neutrophils can then undergo (3) diapedesis to the site of injury and infection.
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Upon their recruitment, neutrophils act to clear invading microbes and debris by
phagocytosis and intracellular killing mechanisms involving the generation of reactive
oxygen species (ROS) and degranulate to release a variety of antimicrobial peptides, proinflammatory cytokines and hydrolytic enzymes (31-34)(35). Neutrophil granules contain
multiple antimicrobial molecules and proteases including elastase, cathepsins, matrix
metallopeptidase-9 and human neutrophil peptide-1 (34). Binding of pathogen-associated
molecular patterns (PAMPs), such as formyl-Methionyl-Leucyl-Phenylalanine (fMLP),
lipopolysaccharide (LPS) and other toll-like receptor (TLR) and triggering receptor
expressed on myeloid cells-1 (TREM-1) ligands, to pattern recognition receptors (PRRs)
promotes neutrophil activation. Cytokines including granulocyte-macrophage colonystimulating factor (GM-CSF), interleukin (IL)-15 and IL-18, can also prime neutrophils
resulting in delayed or decreased apoptosis which subsequently lead to enhanced
neutrophil effector functions (36-38). Activated neutrophils can then release cytokines
and chemokines such as tumor necrosis factor- (TNFα), IP-10, macrophage
inflammatory protein-1α (MIP-1α), IL-12, KC, MIP-2, vascular endothelial growth factor
(VEGF) among others to help drive the subsequent immune response (39).
In addition to pathogen recognition and inciting an inflammatory response,
neutrophils play a critical role in clearance of invading pathogens. One mechanism for
removal of foreign pathogens is the Fragment, crystallizable gamma receptor (FcR)mediated phagocytosis pathway (Figure 3). An invading organism is recognized by one
of three FcR (CD16, CD32 or CD64) and is internalized in a Ras-related C3 botulinum
toxin substrate 2 (Rac2)-dependent manner. Activation of Rac2 , a small GTPase,
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promotes interaction with cytosolic p67

phox

to form and recruit the nicotinamide adenine

dinucleotide phosphate (NADPH) oxidase complex to the maturing phagosome to
mediate bactericidal functions (32, 40-42). Defects in the NADPH oxidase system, such
as in chronic granulomatous disease, are associated with increased susceptibility and
recurrent bacterial infections (43).
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Phagocytosis-Induced
NADPH Oxidase
Activation

and

S. aureus

KC

p22

CXCR2

gp91

FcR
Rac2

PLC

p67
p40

p47

DAG-GEFs
NADPH Oxidase Complex
Rap1
Figure 3. Neutrophil phagocytosis and assembly of the NADPH oxidase complex.

Integrin
Activation

Neutrophils play a critical role in clearance of foreign pathogen via FcR-mediated
phagocytosis. Following interaction between the FcR and a pathogen, internalization
and activation of the small GTPase Rac2 promotes interaction of the cytosolic p67phox
complex with membrane bound p22 and gp91. Together, the NADPH complex is then
guided to the maturing phagosome to help generate ROS and promote bactericidal
activity.
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Numerous studies in human and rodent models suggest that aging alters the
circulating neutrophil pool and negatively impacts neutrophil effector functions, and that
these changes can be amplified in the setting of trauma, infection and tissue injury (5, 4452). With increased aged, there is a shift in the hematopoietic stem cell (HSC) pool
towards generation of myeloid lineage cells, including neutrophils (reviewed in (53)). To
extend these findings, Miyamoto et al. examined the impact of forkhead box O3a
transcription factor (FoxO3a) in regulation of HSC differentiation in aged mice (54). The
family of FoxO transcription factors mediate many cellular processes (55), and has been
shown to be a player in HSC differentiation via modulation of oxidative stress (55).
Considering the contribution of oxidative stress to immune dysregulation with age
(reviewed in (56)), the impact of this particular pathway in the maintenance of the
circulating neutrophil pool is of interest. Data from this group demonstrated that during
recovery from myelosuppressive treatments, aged FoxO3a deficient mice exhibited
profound neutrophilia compared to young knockout mice (54). This increase in
neutrophils was associated with loss of inhibition of FoxO3a on Sprouty-related
Ena/VASP homology 1 domain containing proteins 2 (Spred2), a negative regulator of
cell proliferation, as well as activation of AKT and extracellular signal-related kinase
(ERK) in the aged knockouts. This study provides a novel insight into maintenance of the
HSC pool in aging, and extensions of these studies to examine the affect of age on
expression of the FoxO family of transcription factors may further characterize the
hematopoietic disruption and altered neutrophil development and function observed in
aged animals.
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Trauma and Tissue Injury
In the setting of systemic insults, such as those seen following traumatic injury or
sepsis, an over-exuberant neutrophil response may contribute to the systemic immune
response syndrome, and the associated morbidity and mortality in aging patients (57-59).
Since the age of the patient is a major clinical predictor of outcome following trauma,
several murine studies have investigated how neutrophils as early immune mediators may
be contributing to poor clinical outcomes after major trauma and tissue injury (11, 4850). Our laboratory has previously shown that aged mice exhibit increased mortality
following a 15% total body surface area full-thickness burn trauma as compared to young
mice subjected to the same injury (11). These aged mice have elevated levels of the
neutrophil chemokine KC in lung tissue which translated into heightened neutrophil
infiltration and pulmonary inflammation 24 hours following burn injury (48).
Administration of anti-CXCR2 antibody in aged mice reduced levels of neutrophil
accumulation and pulmonary inflammation to levels observed in young mice (48),
perhaps suggesting that modulating the neutrophil response following systemic insult
may decrease pulmonary co-morbidities. Extending these studies, we observed that
expression of endothelial ICAM-1 was elevated on the pulmonary endothelial cells
following burn injury in aged mice as compared to young, suggesting that the age-related
changes in the pulmonary vasculature that wound impact neutrophil extravasation with
advanced age (60). These data are supported by reports that neutrophils from elderly
donors demonstrated increased adherence to an endothelial cell monolayer following
fMLP or phorbol 12-myristate 13-acetate (PMA) stimulation (61). However, two other
studies determined that neutrophil adhesion to endothelial cells, expression of adhesion
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molecules and neutrophil recruitment were comparable between young and aged donors
(46, 62). These studies highlight differences not only between human and murine models,
but also highlight how aging can exacerbate differences between neutrophil responses
prior to and post injury.
In the setting of local tissue injury, alterations in neutrophil infiltration may also
play a role in delayed resolution with advanced age. Following cutaneous tissue injury,
neutrophils are the first phagocyte to enter the wound bed, helping to incite an
inflammatory response against invading organisms. In aged BALB/c mice, Swift et al.
observed a significant delay in wound closure as reported in other studies (49, 50, 63,
64). Though age-related differences in neutrophil recruitment to the site of cutaneous
injury were observed at early time points, they did not reach significance (50).
Conversusly, Nishio et al. demonstrated that neutrophil peak infiltration was delayed in
aged C57BL/6 mice following cutaneous injury (49). Moreover, Gr-1 mediated
neutrophil depletion further delayed wound closure in aged mice. Systemic
administration of G-CSF or topical application of peritoneal-derived neutrophils from
young mice restored rates of wound closure to those observed in young mice (49). This
reduced neutrophil chemotaxis with advanced age is recapitulated in ex vivo murine and
human studies. In BALB/c mice, we recently reported that neutrophils from aged mice
demonstrate a hyperchemokinesis in the absence of a neutrophil chemotatic stimulus;
however, in the presence of increasing doses of KC, neutrophils from aged mice
demonstrate a marginal chemotatic response as compare to neutrophils from young mice
(60). Similarly, peripheral blood neutrophils isolated from healthy, aged subjects
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conforming to the SENIEUR protocol demonstrated reduced migration towards fMLP
and GM-CSF (45).
Though fetal or adult wound healing studies often consider neutrophil recruitment
detrimental to wound closure and scar formation (65), these studies highlight how
findings in young model organisms are not always directly applicable to the aged
organism. Moreover, the differing results in these between human and rodent studies
reflect a major caveat in aging research. Namely, contradictory results between human
and rodent studies can make it difficult to draw parallels between these studies, and
future animal models need to closely mimic clinically relevant scenarios to improve the
correlation between these data sets. Additionally, different animal strains can lead to
alternative outcomes, further complicating rodent research models. Future in vivo rodent
models and injury paradigms should be evaluated to determine their relative correlation
with findings in human studies to optimize rodent aging research. Though additional
studies need to be conducted to better establish the role of neutrophils in wound healing
and trauma, the impact of advanced age on neutrophil infiltration kinetics and function
may contribute to adversus clinical outcomes such as suboptimal healing and infectious
complications in the elderly.

Infection and Environmental Exposures
Neutrophils are critical for effective recognition and removal of debris and
foreign pathogens. A major pathway that aids in recognition of non-native particles is the
TLR pathway. In humans, aging does not impact basal levels of TLR2 and TLR4
expression on neutrophils (45). However, aging does increase neutrophil TLR4
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expression in unstimulated lipid rafts and non-raft fractions compared to the young mice.
Stimulation with the TLR4 ligand LPS markedly induced TLR4 recruitment to lipid rafts
in young mice; however, aged mice did not alter recruitment or redistribution of TLRs
between lipid raft and non-raft fractions (45). Expression of MyD88, a common
downstream signaling molecule of several TLRs, on neutrophils isolated form young and
aged mice was comparable after LPS stimulation. Interestingly, in the same study,
parallel work in human neutrophils demonstrated reduced membrane-associated MyD88
in neutrophils from aged subjects after stimulation (45).
Similar to difference in membrane/raft-associated TLRs and MyD88, TREM-1
localization to lipid rafts was decreased with age following exogenous stimulation and
this correlated with reduced TREM-1-induced neutrophil functions including
degranulation, phagocytosis, ROS production and production of pro-inflammatory
cytokines and chemokines (66). Of note, elevated circulating levels of soluble TREM-1
are associated with heightened inflammation as well as morbidity and mortality in
critically ill patients with sepsis (67). In addition to TREM-1, Fc receptors play a
predominate role in neutrophil phagocytosis and ROS generation. Studies in neutrophils
isolated from healthy, elderly subjects demonstrate decreased FcRIII expression (CD16),
and this correlated with reduced phagocytic potential. Together, these data suggest a
potential for reduced pathogen recognition, phagocytosis and bactericidal potential with
age that may negatively impact outcomes following bacterial or viral infection in aging
subjects.
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The studies mention above primarily focused on ex vivo stimulation of neutrophils
to generate age-dependent changes in neutrophil effector functions. To extend these
studies, others have examined the impact of age on neutrophil function in in vivo models
of infectious challenge or environmental exposures (51, 52, 68-70). In one such study in
aged mice, exacerbated LPS-induced pulmonary inflammation was correlated with
increased lung levels of KC, MIP-2, IL-1 and prolonged pulmonary neutrophilia at 72
hours (70). In another model of pulmonary challenge, intranasal infection with
Francisella tularensis lead to an altered lung inflammatory response, with a delay in
production of neutrophil chemokines MIP-2 and CXCL6 and attenuated neutrophil
infiltration into the lung tissue in aged mice (51). Moreover, environmental insults, such
as air pollutants or cigarette smoke, contribute to airway inflammation and chronic
pulmonary co-morbidities (71, 72). Aged mice subjected to inhaled diesel exhaust
demonstrate enhanced pulmonary congestion and neutrophilia 24 hours after exposure as
compared to young mice (52). Similarly, single or chronic cigarette smoke exposure in
aged mice resulted in elevated levels of KC and MIP-2, and prolonged neutrophil
recruitment to the lung (73). This age-related increase in cytokine production was
associated with amplified nuclear factor (NF)-B expression and nuclear translocation
(73). Looking at these findings, in response to pulmonary challenge, aged mice have an
elevated and/or prolonged neutrophil response. Considering the delicate lung alveolar
architecture and the highly hydrolytic enzymatic degranulation products of activated
neutrophils, this may contribute to excessive tissue damage and reduced lung function
over time.
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The role of neutrophils in other models of infection have also garnered interesting
data. Following oral infection with Salmonella Typhimurium, aged mice have elevated
bacterial colonization in the ileum, colon, Peyer’s patches, mesenteric lymph nodes
(MLN) and liver as compared to young mice (68). Despite a baseline elevation in
neutrophil numbers in the spleen and MLN of aged mice, aged mice did not increase
neutrophil numbers in response to infection whereas young mice mounted a more
significant neutrophil response (68). Following challenge with the fungal pathogen
Candida albicans, decreases in neutrophil recruitment to the peritoneal cavity were
associated with reduced fungicidal activity in aged mice (74), again highlighting how
neutrophil recruitment may be dysregulated with advanced age.
Combined, these studies offer significant evidence suggesting that neutrophil
recognition, phagocytic potential and infiltration kinetics are dysregulated with aging.
This dysfunction may have pleiotropic effects on the host depending on the inciting
injury or clinical paradigm by promoting pathogen dissemination, compromising organ
function and delaying time to recovery. While altered neutrophil pathogen recognition,
infiltration and phagocytosis may impair the ability of the innate immune response to
contain microbes to site of origin, prolonged neutrophilia can result in significant tissue
damage and inflammation via potent neutrophil hydrolytic enzymes, demonstrating the
importance in precise temporal regulation of this particular immune cell subset.
Macrophages
Macrophages play pivotal roles in modulating immune and stromal cell function
following infection, tissue injury and in tumor cytotoxity (75-77). Following
extravasation from the peripheral blood pool, monocytes undergo maturation into tissue
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macrophages. As professional antigen presenting cells, macrophages help shape the
innate and adaptive immune responses through the release of a variety of proinflammatory mediators at early time points following injury or infection. Collaboration
of macrophages with T and B cells is further mediated by the release of cytokines,
chemokines, enzymes, arachidonic acid metabolites and reactive radicals (78, 79).
Macrophages also serve to dampen the inflammatory response through phagocytosis of
apoptotic cells and secretion of soluble factors like IL-10 (80). Age-related alterations
in macrophage number and function have been correlated with enhanced susceptibility
to infection, differential responses to tissue injury and enhanced tumor progression in
rodent models (74, 81-83).

Macrophage Population Dynamics
With age, there is some discrepancy regarding changes in innate and adaptive
immune cell numbers in rodent and human studies (68, 83, 84). In circulation, the number
of blood monocytes in aged and young subjects appears to be comparable; however, there
is a significant decrease in macrophage precursors as well as macrophages in the bone
marrow of the elderly (85, 86). This may be related to a longitudinal decrease in
macrophage bone marrow production over the human lifespan as a decrease in the
percentage of cells expressing the CD68+ cells, a macrophage marker, was observed in
bone marrow from adults as compared to children (86). In murine studies, one report
suggests that there is an increase in the Mac1/CD11b population in aged murine bone
marrow (87), though others have found there were no differences in the number or DNA
content of developing macrophages between young and aged mice (84). In other cellular
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compartments, aged mice have been reported to have increased resident macrophages in
the spleen (68), though there is a reduction in the marginal zone macrophage population
and a breakdown of the marginal zone architecture with advanced age (83). This collapse
in marginal zone structure may impair clearance of circulating pathogens and follicular
responses in the elderly, increasing susceptibility to infection and prolonging recovery.
Though human and rodent studies have yet to generate a conclusive answer regarding
macrophage numbers in various compartments, alterations in macrophage environmental
distribution may generate organ specific dysregulation. For example, increased
infiltration of macrophages into adipose tissue of aged C57/BL6 mice fed high caloric
diets was associated with increased inflammasome activation and cytokine production
(88). These data suggest that a tissue-specific shift in macrophage populations can
contribute to basal differences in the inflammatory profile of aged individuals.

Cytokine Production and TLR Signaling
In rodent models, advance aged is associate with increased levels of circulating
cytokines, in particular IL-6, and it has been speculated that changes in these proinflammatory mediators may alter immune function in aged animals (11, 89-91).
Despite this basal elevation, challenge of bone-marrow derived macrophages with
Porphyromonas gingivalis (P. gingivalis) produce significantly less tumor necrosis
factor- (TNF-and IL-6 in aged mice (92). The influence of aging on LPS-mediated
cytokine production selectively impact macrophage responses, such that some functions
are depressed while others are elevated. For example, macrophages from aged mice
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have increased levels of cyclooxygenase-2 and produced elevated levels of
prostaglandin E2 and IL-10 after LPS stimulation (93-95), whereas TNFα, IL-6 and IL1 and IL-12 production are decreased as mentioned above. Similarly, in response to
LPS, splenic macrophages from aged wild type mice demonstrated diminished
responsiveness to LPS stimulation, producing lower levels of TNF-, IL-1, IL-6 and
IL-12 as compared to young controls (96). Interestingly, cytokine production was
restored following in vitro culture of LPS with splenic macrophages from aged IL-6
deficient mice (96), suggesting that elevated systemic IL-6 may directly impair
macrophage function in aged animals. Several studies also support a similar reduction
in cytokine production, including TNF-, IL-6, IFN-, nitric oxide (NO), monocyte
chemoattractant protein-1 (MCP-1) and MIP-1, following a variety of stimuli (68, 74,
92, 97).
Generation of cytokines is often examined following stimulation of a variety of
TLRs. TLRs help initiate the innate immune response to a variety PAMPs, and signal
through either MyD88-dependent or –independent pathways to promote NF-B proinflammatory cytokine production. Reduced expression of these receptors, or
alterations in their respective downstream pathways, can increase susceptibility to
infection (98-100), and a number of studies demonstrate alterations in the macrophage
TLR expression and/or signaling in aged animals and humans. In both splenic and
peritoneal macrophages of aged C57/BL6 mice, decreased expression in all TLRs
(TLR1-9) have been found (74, 101), though other studies report no difference in
expression of some TLRs, including TLR2 and TLR4, in aged BALB/c (82, 102, 103).
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A study of 159 young and aged individuals found an age-associated reduction in TNFα
and IL-6 by peripheral blood monocytes after stimulation with TLR1/2 that correlated
with reduced surface expression of TLR1 (104). An age-associated decrease in TLR4
surface expression and and TLR7-induced IL-6 production was also observed in this
study (104). Recent research provided similar evidence for age-associated defects in
TLR function in human macrophages in the context of infection with West Nile virus
(99).
While divergent results regarding TLR expression may be due to purity of the
isolated macrophage population or murine background strain, the pathways downstream
of TLRs may also be impaired with age. In one such study, LPS or zymosan induced
TNF- and IL-6 production was attenuated in splenic macrophages from aged mice due
to reduced activation of p38 mitogen-activated protein kinase (MAPK), MAPKactivated protein kinase-2 and NF-B (102). Others have shown that thioglycollateelicited peritoneal macrophages from aged mice exposed to P. gingivalis have increased
gene expression of the single immunoglobulin interleukin-1-related receptor (SIGIRR)
which acts to inhibit TLR MyD88-dependent signaling (103, 105). In aged rodent
models, downregulation of other members of these pathways, like MyD88 and tumor
necrosis factor receptor-associated factor 6 (TRAF6), lead to decreased activation of the
NF-B family of transcription factors (69, 106). While studies have shown that age
does not affect the basal levels of LPS-binding protein (96), levels of CD14, a coreceptor for TLR2 and TLR4, were reduced in macrophages from aged mice (107).
Downregulation of mediators of the TLR pathways would dampen the immune
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response, and may account for the decrease in cytokine production seen in aged rodent
and human macrophages following immunogenic challenge.

ROS/RNI Generation and Macrophage Phenotype
Another major mediator of macrophage effector function is the generation of
ROS and reactive nitrogen intermediates (RNI) that aid in intracellular microbicidal
activity and tumor cytotoxicity. ROS and RNI, alongside IL-1, IL-12, TNF-, represent
the pro-inflammatory M1 macrophage profile, and these cells function in driving Th1
responses, resisting tumor development and killing of intracellular foreign pathogens
(80). On the other hand, M2, or anti-inflammatory, macrophages have elevated levels of
IL-10 and arginase expression. M2 macrophages predominately function in
immunoregulation, neovascularization, tissue remodeling and tumor growth (80, 108).
Macrophages from aged mice had been shown to produce elevated levels of IL-10 and
reduced FasL, IL-12 and TNF-, mediators that contribute to an M2 anti-inflammatory
profile (109). Several studies have also reported decreases in ROS or RNI generation
with age that may represent a skewing of M1 and M2 polarization with age (81, 110,
111). As compared to young animals, alveolar macrophages from senescent rats
demonstrated a decreased baseline generation of ROS and NO, and LPS treatment did
not significantly change ROS and NO production in aged animals (110). In response to
PMA or zymosan, peritoneal macrophages from aged mice produce 50% less hydrogen
peroxide (H2O2) in contrast to cells from young animals (111). These studies are
supported by previous reports in which NO production by splenic or peritoneal
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macrophages was reduced in several mouse strains following LPS or peptidoglycanpolysaccharide (112). In addition to these findings, macrophages from aged mice
exhibit reduced GM-CSF mediated cell proliferation following exposure to H2O2 due to
diminished signal transducer and activator of transcription (STAT) 5a oxidation and
phosphorylation, suggesting that aging increases macrophage susceptibility to oxidative
stress (113).
NO production is modulated by enzymatic activity of inducible nitric oxide
synthase (iNOS) via activation of the interferon-gamma (IFN- receptor. In aged
BALB/c mice, mRNA expression of iNOS was found to be decreased after stimulation
with LPS as compared to young mice (112). Similarly, our laboratory has observed
decreased iNOS expression in splenic adherent cells from aged BALB/c mice following
stimulation with IFN- and TNF- (114). As macrophage signaling through the IFN-
receptor promotes ROS and RNI generation, several studies examined if alterations in
this receptor and the downstream signaling pathway may exist with advanced age (111,
115, 116). Though there are no differences in IFN- receptor with age (111, 115),
culture with IFN- reduced H2O2 and NO2- production in aged animals due to decreased
phosphorylation of MAPK (111). Others also found decreased STAT1a gene and
protein expression and reduced STAT1 phosphorylation after in vitro IFN- stimulation
of macrophages isolated from aged BALB/c mice (115). While this reduction in iNOS
and NO production may suggest suppression of M1 macrophages with age, our lab has
also observed a reduction in arginase-1 expression after IL-4 stimulation in adherent
splenocytes from aged mice (114), implying a global immunosuppression of
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macrophage function with age. Together, these studies suggest that the ROS and RNI
pathways are dysregulated with age, translating into potential differences in
macrophage phenotype and intracellular killing capacity, and ultimately negatively
impacting immune function in the elderly.
Contrary to these reports, Chen et al. found enhanced NO production in both
thioglycollate-elicited and resident peritoneal macrophages from inbred CBA/CA aged
mice following culture with LPS, zymosan or heat-killed S. aureus (117). In these
animals, elevated NO production was correlated with a persistent increase in iNOS
expression. Yet another study found no difference in iNOS induction, NO production or
intracellular killing in thioglycollate-elicited macrophages from aged BALB/cByJ mice
in response to in vitro stimulation with P. gingivalis (103). These studies highlight that
a variety of factors, including the murine strain, macrophage population and inciting
stimuli, all play are role in determining potential age-related differences in macrophage
function in rodent models.

Tissue Injury
As temporal changes in macrophage phenotype have been implicated in wound
resolution, alteration in macrophage phenotype and function in aged animals may
provide insight into altered tissue repair with advanced age (50, 64, 118). In particular,
in murine models of tissue injury, aged animals have a prolonged course of wound
repair, associated with delays in re-epithelialization, neovascularization and restoration
of the extracellular matrix (63). Following excisional wound injury, macrophage
accumulation was elevated 56% at day 1 in aged mice as compared to young, and this
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correlated with increased MCP-1 production (50). In macrophages isolated from
subcutaneous implanted polyvinyl alcohol (PVA) sponges, aged mice demonstrated an
approximate 40% decrease in phagocytosis as compared to young mice (50). These
delays in wound closure and diminished phagocytic ability of wound cells may
contribute to the increased susceptibility to infection seen in elderly patients (119-121).
Additionally, reduced macrophage phagocytosis may impair the ability to clear
apoptotic keratinocytes or neutrophils from the wound bed, further delaying wound
repair. Aprahamian et al. recently demonstrated that following ultraviolet B irradiation,
aged mice demonstrated an elevated percentage of apoptotic keratinocytes compared
young irradiate mice that was later correlated with reduced phagocytic capacity and
apoptotic cell clearance in aged animals as compared to young (122).
As macrophages act as to bridge the innate and adaptive immune responses, an
interesting study by Agius et al. recently demonstrated that cutaneous delayed-type
hypersensitivity responses to bacterial, fungal or viral antigens by CD4+memory T cells
is significantly decreased in older subjects (123). The defective T cell
immunosurveillance was attributed to diminished production of TNF-α by cutaneous
macrophages, resulting in reduced endothelial activation and a subsequent decrease in T
cell recruitment to the aging skin. This study emphasize how a defect in the
macrophage population with advanced age not only impairs the innate arm of the
immune system, but can compromise the pathogen-specific adaptive immune response
and result in a poor prognosis following injury and infection. Together, these findings
may provide the foundation for improving our understanding of poor clinical outcomes
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following tissue injury and infection with aging, and may lead to design of therapeutic
interventions to enhance macrophage function and accelerate wound closure.

Tumor Immunity
Deficits in macrophage function also directly contribute to the increased
incidence of neoplastic growth and metastasis in elderly patients. In tumor
immunology, recruitment of tumor associated macrophages (TAMs) results in the
release of growth factors, proteases and inflammatory mediators, promoting
vascularization of tumor tissue and metastasis (124). Infiltration of tumors by TAMs is
associated with a poor prognosis (124), and age-related differences in TAM effector
functions within tumors have been identified (125). In a B16 intraocular tumor model,
aged mice exhibit increased infiltration of M2-polarized macrophages in contrast to
young mice. These macrophages had elevated expression of pro-angiogenic VEGF and
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 (TIE-2) (125).
Depletion of macrophages by subconjunctival injections of clodronate-containing
liposomes reduced tumor growth in 86% of mice compared to only a 10% reduction in
young animals. Interestingly, the M2 macrophages in tumors from aged mice shared
some phenotypic characteristics of myeloid-derived suppressor cells from the
monocytic lineage, namely Ly6-C (125) and were also subject to depletion by the
methods used above. In addition to TAM recruitment, macrophages from aged rodents
have elevated cycloxygenase activity and prostaglandin E2 synthesis, mediators that
have been recently implicated in tumorigenesis (93, 126). Further work to better
characterize TAMs with aging and cancer subtypes may aid in development of targeted
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cancer treatments for patients with poor prognoses due to TAM infiltration and
subsequent neovascularization and metastasis.
Age-related differences in macrophage function described above highlight how
alterations in macrophage phenotype and function can facilitate development of
infection, delays in tissue repair and impairment of tumor regression. Utilizing targeted
rodent models to increase our understanding of how macrophages can contribute to
specific pathological conditions may position us to better understand disease states at
the bedside.

Summary of Aging and the Innate Immune System
Age-associated impairment in the various components of the immune system has
been extensively studied. However, it is evident from the recent studies reported herein
that some aspects of innate immunity require more investigation than others (e.g. AMPs).
Tackling immunosenescence as it affects the innate arms of the immune system is a
logical step forward as efficient antigen presentation and co-stimulation by macrophages
and dendritic cells may promote a ‘normal’ humoral and cell-mediated immune response
in aged individuals. Moreover, future aging research should focus on the key signaling
molecules modulating the various signaling pathways involved in phagocyte and antigen
presenting cell (APC) effector responses as well as cross-talk between these pathways.
Furthermore, studying the intrinsic defects of a cell without the interference of the aged
microenvironment is as crucial as focusing on the overall aged phenotype. Tailored and
complementary in vitro and in vivo studies on the complex physiological interactions

30

between innate immune cells and tissue-specific environments can hold a promising
future for aging research.
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Innate Immune Cells as Regulators of Wound Healing
Cutaneous wound healing is a dynamic process requiring coordination of immune
cell infiltration, keratinocyte proliferation, angiogenesis, extracellular matrix deposition
and collagen remodeling to ensure adequate wound closure (127-129). Proper regulation
of this physiologic response to injury by crosstalk between various cell types and soluble
factors facilitates restoration of the epidermal and dermal barrier with minimal scar
formation (127, 130, 131). Multiple pathologic conditions, hormone status and advanced
age are known to perturb efficient cutaneous repair by impacting one of the three
interdependent phases of wound healing: the early inflammatory phase, proliferative
phase or late remodeling phase (Figure 4) (127, 128, 131, 132). Innate immune cells are
critical during these stages of wound repair, as changes in innate immune cell function
have been shown to significantly augment normal wound healing, leading to poor wound
closure or hypertrophic scar formation. Understanding the contribution of the innate
immune response to wound repair and dermal restoration is instrumental in the rational
development of clinical therapeutics that will enhance wound closure, decrease
associated morbidities and reduce critical care costs.
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Figure 4. Phase of cutaneous wound healing. Inflammatory phase: Immediately
following tissue injury, platelets, local immune cells and keratinocytes release soluble
mediators such as AMPs and pro-inflammatory cytokines/chemokines to help kill
invading pathogens and recruit innate leukocytes. Then, neutrophil infiltration occurs as
early as 6 hours and peaks between 18-24 hours in aseptic wound models. Macrophages
are then recruited to help in pathogen and debris clearance, as well as mediating
transition to the Proliferative phase. This phase is marked by angiogenesis, reepithelialization and collagen deposition. Lastly, wounds undergo a long Remodeling
phase. Here, the initial collagen is crosslinked and remodeled in order to increase the
tensile strength of the wound.
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Antimicrobial Peptides as Early Mediators of Wound Healing
Integral to the host defense response at epithelial surfaces, AMPs serve to directly
inhibit bacterial growth and help initiate recruitment of innate leukocytes (17, 133). As
small amphipathic molecules, AMPs mediate bactericidal activity by integration and
disruption of microbial membranes. Within the skin, several classes of AMPs, including
cathelicidins (LL37/CRAMP) and -defensins, have been identified to be important in
response to both infection and injury (13, 134). Human -defensin (hBD1) is
constitutively expressed by keratinocytes, where as hBD-2/mBD-3 and hBD3/mBD14 are
predominately upregulated following inflammation, tissue injury or infection (13-15).
Namely, hBD2-4 have been shown to induce keratinocyte pro-inflammatory cytokine and
chemokine secretion as well as enhancing keratinocyte migration and proliferation (135).
In settings of non-healing wounds, such as diabetic foot ulcers, expression of
activated human cathelicidin, LL37, was reduced compared to tissue from healthy donor
skin (136). In parallel to this, murine studies in CRAMP-/- mice report delayed wound
healing. On the contrary, levels of hBD1-4 were elevated in tissue samples from nonhealing and diabetic foot ulcers (136, 137). Interestingly, in a porcine model of S. aureus
excisional wound infection, treatment with human hBD3 enhanced bacterial clearance
and wound re-epithelialization as compared to controls (138). Together, these data
suggest that alterations in AMP expression or function may contribute to aberrant healing
in pathologic settings, and reconstitution of functional AMPs could provide therapeutic
options for chronic, non-healing wounds.
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Controversial Role of Neutrophils in Wound Repair
Neutrophils are typically described as the first class of infiltrating innate immune
cells at the site of injury, helping to control potential infection by phagocytosis of foreign
pathogens and removal of contaminating debris. Despite this necessary function,
excessive release of enzymes by neutrophils, such as elastase, can be damaging to
surrounding tissue, delaying rates of healing and increasing the risk of scar formation (65,
130, 139, 140). For these reasons, the need for neutrophil infiltration following injury is
heavily debated. In support of neutrophil-dependent wound healing, mice lacking the
CXCR2 receptor responsible for neutrophil chemotaxis have an expected impairment in
neutrophil recruitment to the site of injury (141). Interestingly, this was accompanied by
decreased re-epithelialization and angiogenesis (141). Despite insufficient neutrophil
recruitment, monocyte and macrophage infiltration was actually enhanced in CXCR2
deficient mice (141), suggesting that loss of the neutrophil population may alter the
important, yet ill-defined, cross-talk between these two cell subsets in the context of
wound healing. Moreover, aging studies support the necessity for neutrophil infiltration
for efficient wound closure. In these studies, neutrophil depletion further impairs rates of
wound closure in aged mice (49). Additionally, topical application of isolated peritoneal
neutrophils following injury or intravenous injection of G-CSF to mobilize neutrophils to
the peripheral pool prior to wounding, enhanced rates of wound closure to that seen in
young mice (49). These data imply that topical or systemic G-CSF treatment may provide
a potential therapeutic avenue for neutropenic or immunocompromised individuals, such
as cancer patients or the elderly, who may not be able to recruit adequate numbers of
neutrophils to site of cutaneous injury and infection.
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On the other hand, studies in young mice report a very divergent finding
regarding neutrophil necessity in cutaneous repair. In vivo neutrophil depletion in young
mice with rabbit anti-mouse sera prior to injury resulted in increased re-epithelialization
out to day 3 post injury with no significant difference in macrophage infiltration (140).
The evidence provided by Dovi et al. is supported by earlier findings that conclude
neutrophils are either dispensable in cutaneous repair (142) or that their excessive
presence is detrimental to the healing process (143). In the later study, impaired healing
in a murine model of diabetes was associated with prolonged expression of MIP-2 and a
concomitant extended infiltration of neutrophils at the site of injury (143). Also arguing
against a positive effect of neutrophil recruitment to sites of aseptic injury are fetal
wound healing models. Fetal wound healing is characterized by a pronounced decrease in
inflammatory mediators and neutrophil recruitment at injury sites, minimal, if any scar
formation, and swifter rates of wound closure (130, 131). While these data suggest that
neutrophils may either be unnecessary or detrimental to prototypic wound repair, the
aging studies provide an interesting point of contention. The differences observed in fetal,
young and aged mice may actually highlight an aging difference reflective of the
immunosenescent phenotype of the elderly, suggesting that modulation of wound closure
by neutrophils may be required in the elderly yet detrimental in utero and in younger
patients. While the current data are somewhat inconclusive regarding the positive and
negative contribution of neutrophils to efficient wound repair, similar to many
physiologic processes, it is highly likely that maintenance of a delicate balance is ideal
for satisfactory wound repair.
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Macrophages as Critical Mediators of Wound Healing
There is a general acceptance that macrophages are instrumental in prototypic
wound healing, being involved predominately in the inflammatory and proliferative
phases of wound repair. Their crucial role is highlighted as impaired macrophage
function or alterations in macrophage infiltration kinetics and duration are associated
with a prolonged inflammatory response, inadequate wound closure and poor restoration
of normal cutaneous architecture (127, 144-148). The critical function of macrophages is
emphasized by studies utilizing selective depletion of the macrophage population
immediately prior to injury (144). In these studies, macrophage ablation was associated
with increased TNF- production and delayed re-epithelialization at 5 days post injury.
These mice also exhibited decreased angiogenesis, as noted by diminished CD31+
staining and reduced VEGF production, as well as impaired collagen production and
decreased transforming growth factor – (TGF- production, implying that macrophages
help modulate the wound inflammatory milieu and progression into the proliferative
phase of wound healing (144).
In addition to evidence supporting an absolute requirement for macrophages in
efficient repair, reports suggest that macrophage phenotype plays a significant role in the
modulation of the response to cutaneous injury (118, 145, 149). Following injury,
peripheral blood monocytes extravasate to the wound site, undergoing differentiation into
wound macrophages (79, 118). While initially thought of as alternatively activated, or
M2-polarized, macrophages, emerging evidence supports that the first macrophages
entering the wound site display a pro-inflammatory phenotype, marked by TNF- and
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IL-6 production (118). As the inflammatory phase progresses, wound macrophages
increase production of TGF- and express typical markers of alternative activation,
including arginase1 and Ym1 (118). Interestingly, prolonged expression of classical
markers of activation in wound macrophages is tied to failure of efficient wound
resolution (145), implying that timely transition to an M2 phenotype is required for a
competent physiologic response to cutaneous injury. Based on evidence that M2
macrophages enhance wound repair, recent studies have utilized mesenchymal stem cells
(MSC) to drive M2 polarization (149). Zhang et al. found that co-culture of gingivaderived MSCs could effectively home to sites of cutaneous injury, induce an M2
phenotype and remarkably accelerate wound closure (149). While studies exploring the
therapeutic potential of stem cells in human and animal models of cutaneous injury have
consistently provided evidence that MSCs promote wound repair (reviewed in (150)), this
is one of the first reports to postulate a mechanism by which MSCs directly interact with
wound immune cells to enhance closure.
Stem cell therapeutic interventions which augment macrophage function may be
of particular interest in several patient populations, such as the elderly and diabetics (50,
64, 119, 145, 151, 152). These patients are often plagued by prolonged rates of wound
closure that are attributable to impaired macrophage function (50, 143, 145, 147). Wound
macrophages in diabetic models exhibit decreased phagocytic function and heightened
pro-inflammatory cytokine production (147), which may impair resolution and elevate
the risk of infectious complications in a clinical setting. This impaired phagocytic
capability was specifically characterized as defective macrophage efferocytosis (147), or
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phagocytosis of apoptotic cells (153, 154). Increased apoptotic cell content in wounds
from diabetic mice was associated with an overall delay in wound closure. Culture of
isolated wound macrophages from diabetic mice with apoptotic thymocytes demonstrated
a reduced ability clear dead cells (147). In line with this study, diabetic murine models of
excisional skin injury or skin flap cutaneous injury demonstrated increased levels of
MCP-1 in cutaneous wounds (143, 145). Heightened production of this chemokine
correlated with enhanced macrophage infiltration and delayed wound closure (143) or
reintegration of the injured flap (145). These data parallel studies in aging mouse models,
in which impaired cutaneous wound closure in aged mice is associated with elevated
MCP-1, increased macrophage infiltration and the prolonged presence of macrophages at
the site of injury (50). Taken together, these data highlight the absolute necessity for
intact macrophage function to effectively modulate the inflammatory and temporal
response to wound injury. Perhaps treatment of clinically compromised wounds with
MSC could not only aid in transition to the anti-inflammatory phenotype seen in both
diabetics and the elderly, but rescue defective efferocytosis and phagocytosis to further
aid in wound repair. As the knowledge of macrophage involvement in wound repair
advances and evolves, this particular innate immune cell subset is likely to emerge as a
key candidate for targeted intervention and treatment in non-healing, chronic wounds in
at risk patient populations.

Langerhan’s and Mast Cells in Cutaneous Wound Healing
Two additional innate leukocytes have been shown to have a hand in modulation
of wound resolution, Langerhan’s cells (LC) and mast cells (MC). LCs, resident dendritic
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cells of the epidermis, have been shown to have differential responses to two types of
non-healing cutaneous ulcers: venous leg ulcers and diabetic foot ulcers (137). In patients
with venous leg ulcers there was a decreased accumulation of CD1a+ LC at the site of
injury as compared to aged matched controls. Conversusly, there was a marked increase
in CD1a+ LC in patients with diabetic foot ulcers in comparison to controls. The authors
attributed this difference to increased expression GM-CSF in keratinocytes present in
diabetic foot ulcers (137). In an alternate study, enhanced LC accumulation was actually
tied to excessive scar formation, as opposed to chronic wounds (155). Niessen et al.
found that the number of LC in the epidermis was elevated in hypertrophic scars at 3
months after surgery, though no difference was noted at 12 months (155). Clearly these
studies outline that LC aid in regulation of wound repair, but their precise functional
contributions are yet to be delineated.
Mast cells, another epidermal resident leukocyte with known functions in
autoimmune and inflammatory pathology, have been postulated to play a role in
cutaneous wound healing (156-158). Studies utilizing MC-deficient mice have found that
absence of MC delays wound closure and results in dysregulation of the inflammatory
stage of wound healing through impaired neutrophil recruitment (157, 158). Weller et al.
extended these findings by examining the role of MC histamine release as a potential
mediator of the impaired wound closure seen in MC-deficient mice. These studies found
that blockade of histamine 1 receptors impaired wound closure, and suggested that
histamine release by activated MC may mediate the positive effect of MC on cutaneous
healing (157). As histamine, a potent vasodilator, is common place in clinical practice,
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topical application may serve as yet another targeted therapeutic to enhance wound
closure and improve clinical outcomes following tissue injury.

Summary of Innate Immune Cells as Mediators of Wound Healing
The physiologic response to cutaneous injury is undoubtedly a complex, highly
regulated process. Likewise, the contribution of innate immune leukocytes and
lymphocytes to this efficient wound repair process is multifaceted. As these cells are
some of the earliest responders and mediators of the local response to cutaneous injury,
they serve as ideal targets for modulation of the wound repair process. Early intervention
in at risk patient populations with novel therapeutic strategies derived from our
understanding of the innate mediators of tissue injury can potentially decrease the
incidence and prevalence of chronic, non-healing wounds, reduce infectious
complications and ameliorate associated health care costs.
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Overall Significance:
Age-Associated Alterations in Innate Immune Function and Wound Repair
Increased human life expectancy over the last century has resulted in growth of the aging
population; however, the prevalence of disease and associated morbidities among the
elderly has also increased (1). Older patients are more susceptible to post-surgical
infections and subsequent problematic wound closure with costly prolonged hospital
stays (121, 159). In addition, these patients suffer from chronic wound states that offer
persistent sites for infection by foreign pathogens (119, 151), potentially propagating
infectious spread in long-term care settings. By determining how aging impairs innate
immune cell function, novel therapeutic approaches that aid in resolution of wound
infection may be realized, resulting in improved post-surgical outcomes, diminished rates
of chronic wounds and a clinically significant reduction in morbidity and mortality in the
elderly.

CHAPTER 3
REDUCED NEUTROPHIL CHEMOTAXIS AND INFILTRATION CONTRIBUTES
TO DELAYED RESOLUTION OF CUTANEOUS WOUND INFECTION WITH
ADVANCED AGED
Abstract
Advanced age is associated with alterations in innate and adaptive immune responses,
which contribute to an increased risk of infection in elderly patients. Coupled with this
immune dysfunction, elderly patients have elevated rates of wound dehiscence, chronic
wounds and wound infection, suggesting that aging impairs wound healing. To evaluate
how advanced age alters the host immune response to cutaneous wound infection, we
developed a murine model of cutaneous S. aureus wound infection in young (3-4 month)
and aged (18-20 month) BALB/c mice. Aged mice exhibit increased bacterial
colonization and delayed wound closure over time compared to young mice. These
differences were not attributed to alterations in wound neutrophil or macrophage TLR2 or
FcRIII expression, or age-related changes in phagocytic potential and bactericidal
activity. However, reduced neutrophil and macrophage recruitment was observed in aged
mice relative to young mice despite elevated KC, MIP-2 and MCP-1 chemokine levels at
the wound site. In response to a subcutaneous injection of KC, aged mice recruited fewer
neutrophils at increasing doses of KC compared to young mice, suggesting age impairs in
vivo neutrophil chemotaxis to cutaneous tissue. These age-mediated defects in early
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neutrophil recruitment may alter the dynamics of the inflammatory phase of wound
healing, impacting macrophage recruitment, bacterial clearance and wound closure.
Introduction
An estimated 25 billion dollars in US health care expenditure is spent on care of
chronic, non-healing wounds (151). One patient sub-population, the elderly, account for a
major portion of patients afflicted by chronic and infected wounds (119, 151, 159). Aging
is associated with a decline in immune function which can elevate rates of wound
infection and delay wound closure in these patients (64, 160, 161). Moreover, advanced
age is associated with a general decline in innate and adaptive immune function which
contributes to an increased susceptibility to opportunistic bacterial and viral infections in
the elderly (6, 159, 162, 163). Underlying this elevated susceptibility to infection are
deficits in host recognition, phagocytosis, migration and activation of a pathogen-specific
adaptive immune response (3, 45, 83, 164). In addition to the immunosenescence that
accompanies aging, advanced age is also marked by heightened levels of circulating proinflammatory mediators in the absence of an inciting stimulus, a state referred to as
“inflamm-aging (56, 165).” Together, these phenomena are thought to contribute to poor
outcomes following infection or trauma in clinical and animal models of aging (47, 48,
89, 159, 166, 167).
Alongside playing a critical role in eradication of foreign pathogens, the innate
immune response is also crucial to tissue repair, another physiologic response
compromised by aging. Cutaneous wound repair is a complex process, marked by
immune cell infiltration and inflammation, fibroblast and keratinocyte proliferation,
angiogenesis, and remodeling of the extracellular matrix to ensure restoration of the
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normal skin barrier (118, 139, 160, 168, 169). Natural and succinct progression through
these interdependent stages of wound healing is required to ensure rapid and adequate
repair of epidermal and dermal architecture. Clinical observations reveal that elderly
patients have an impaired response to cutaneous injury, resulting in elevated rates of
wound dehiscence and subsequent chronic wounds (121, 151). Non-healing wounds in
this patient population have an increased risk of infectious complications. This risk is
associated with higher morbidity and mortality, and infectious spread in long-term care
facilities (120). Moreover, older patients are more susceptible to post-surgical infections
and subsequent problematic wound closure with costly prolonged hospital stays (121,
159).
Laboratory studies using murine models of cutaneous injury have substantiated
the aforementioned clinical findings as advanced age has been shown to alter the
dynamics of all stages of the wound repair process (49, 50, 63, 170). Evidence suggests
age-associated differences in the magnitude and duration of neutrophil and macrophage
infiltration into the wound bed during the inflammatory phase of wound healing (49, 50).
These phagocytes are instrumental in limiting infectious spread and regulation of the
temporal progression through the early phases of wound closure (118, 171, 172). Despite
compromised immune function and increased rates of infectious wound complications in
the elderly, the impact of advanced age on the host immune response to cutaneous wound
infection has been neglected. S. aureus is a common dermatopathogen that accounts for
at least 75% of skin and soft tissue infections and 30% of surgical-site infections, with a
dramatic increase in S. aureus-associated surgical site infections to 50% in patients over
65 (159, 173, 174). We developed a cutaneous excisional S. aureus wound infection
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model in young (3-4 month) and aged (18-20 month) BALB/c mice. In the setting of
wound infection, we are the first to demonstrate that advanced age is associated with
heightened bacterial colonization and delayed wound closure due to reduced innate
immune cell recruitment.

Materials and Methods
Animal Model
3-4 month old (young) and 18-20 month old (aged) BALB/c mice (Charles River/NIA,
Kingston Facility, Stony Ridge, NY) were utilized to determine age-dependent
differences in response to cutaneous wound injury and infection (Figure 5). All animal
studies were approved and performed with strict accordance to the regulations established
by the Loyola University Chicago Animal Care and Use Committee. Following
acclimation at Loyola’s Animal Care Facility, young and aged mice were subjected to
dorsal excisional cutaneous injury as previously described (175). Briefly, mice were
administered intraperitoneal (i.p.) 100 mg/kg ketamine and 10 mg/kg xylazine followed
by i.p. saline to ensure systemic distribution of the anesthetic. Once the mice no longer
responded to firm pressure applied to their hind limb, their dorsum’s were shaved and
cleansed with ethanol pads. Mice were then subjected to 6 dorsal full-thickness (skin and
panniculus carnosa) cutaneous wounds with a 3 mm dermal punch biopsy (Acuderm, Ft.
Lauderdale, FL). Immediately after injury, mice received ~103 colony forming units
(CFU)/10uL of S. aureus to each wound and were returned to their cages on heating pads.
A low inoculum of bacteria was chosen to prevent sepsis which is known to negatively
impact wound healing (176). S. aureus Newman strain was grown overnight in tryptic
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soy broth (TSB) at 37 C under constant agitation. The next day, 1 mL of S. aureus in
TSB was resuspended in 2mL fresh TSB and incubated at 37oC for 2 hours to ensure
mid-logarithmic growth at the time of application to cutaneous wounds. Bacterial
concentration (CFU/mL) was determined by absorbance at 600 nm and the final
inoculum confirmed by back-plating on mannitol salt agar (MSA; BD Diagnostics,
Sparks, MD).
Mice were sacrificed at days 1, 3, 7 and 10 after injury and infection. The pelt was
removed and photographed to measure wound size as described below. A larger 5 mm
punch biopsy was used to remove the 3 mm wounds. Wounds were examined for
bacterial colonization, ex vivo phagocytosis, flow cytometric analysis of wound immune
infiltrate and cytokine and chemokine analysis as detailed below. Blood was obtained via
cardiac puncture for flow cytometric analysis, as well as the bactericidal assay.
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Aged: 18-20 months
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Wound Size
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Figure 5. Model of S. aureus cutaneous wound infection in young and aged mice.
Young (3-4 month) and aged (18-20 month) BALB/c mice were anesthetized and their
dorsum shaved. Mice then received 6, 3 mm dorsal punch wound followed by ~103 CFU
of S. aureus per wound. Mice were sacrificed at days 1, 3, 7 and 10. Wounds were
assessed for bacterial colonization, wound size, inflammatory cell infiltrate, cytokines,
chemokines, phagocytosis and AMPs. The peripheral blood was harvested for evaluation
by flow cytometry.
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Bacterial Colonization
Skin, spleen and kidney were each homogenized in 1 mL sterile phosphate buffered
saline (PBS) and 10-fold serial dilutions to 106 were plated on MSA plates (BD
Diagnostics, Sparks, MD). Heparinized whole blood was directly plated onto MSA
plates. Plates were incubated at 37oC for 24-48 hours and colonies were counted to
determine levels of bacterial colonization. Significant bacterial dissemination to spleen,
kidney and blood was not observed (data not shown).

Wound Size
Wound size was evaluated by digital photography and image analysis as previously
described (175). Briefly, at days 1, 3, 7 and 10 wounds were photographed with a Canon
EOS SLR digital camera. Each pelt photographed at a fixed distance of 20 cm with a
ruler placed within the frame of each photograph. Photoshop 7.0 (Adobe Systems Inc.,
San Jose, CA) was used to determine the number of pixels in the open wound area using
the magic wand tool, with zoom at 100% and a tolerance setting of 60. Separate animals
were sacrificed immediately following wound injury and wound size was determined to
represent day 0. Wound areas at each time point were compared with day 0 wounds:
(pixels at days1-10/pixels at day 0)x100 were used to determine the percent open wound
area at each time point.

Skin and Whole Blood Flow Cytometry
Single cell suspensions of wound cells for flow cytometry were generated as
previously described (177). At days 1-7 after injury and infection, animals were
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euthanized, pelts removed and wounds excised using a 5 mm punch biopsy. Diced
wounds were incubated overnight at 4oC in RPMI 1640 culture media containing 10%
fetal bovine serum (FBS) (Hyclone, Logan, UT), 2 mM L-glutamine (Gibco, Grand
Island, NY), 1% penicillin/streptomycin (Gibco, Grand Island, NY), 2 mg gentamycin
sulfate (Mediatech Inc, Manassas, VA) and 0.3 mg dispase II (Roche Diagnostics,
Indianapolis, IN). The next day, tissue pieces were removed and subjected to further
enzymatic digestion with 1 mg collagenase from Clostridium histolyticum type 1A
(Sigma-Aldrich, St. Louis, MO), 1.2 mg DNAse I from bovine pancreas Grade II (Roche
Diagnostics, Indianapolis, IN), 1 mg hyaluronidase from bovine testes type 1-S (SigmaAldrich, St. Louis, MO), in RPMI 1640 with 5% FBS, 2 mM L-glutamine (Gibco, Grand
Island, NY), 1% penicillin/streptomycin (Gibco, Grand Island, NY), 2 mg gentamycin
sulfate (Mediatech Inc, Manassas, VA) and magnesium chloride hexahydtrate for 2 hours
at 37oC. After two hours, these solutions were combined and debris removed by filtration
with a 70 m filter. Cells that remained adherent to the tissue culture plastic were treated
with Accutase (eBioscience, San Diego, CA) for 5-8 minutes at 37oC followed by
vigorous pipetting. Cells were washed and adjusted to 1x106/mL. Cells were blocked for
20 minutes with FcBlock (anti-CD16/CD32, eBioscience) and rat IgG (Jackson Immuno),
and then stained with PE-Cy7-F4/80 (eBioscience), FITC-Gr-1 (eBioscience, San Diego,
CA), APC-CD3 (eBioscience) or APC-TLR2 (eBioscience, San Diego, CA). Cells were
washed twice and then resuspended in flow buffer (1% bovine serum albumin (BSA),
0.1% sodium azide and 2mM EDTA in PBS). For blood analysis, heparinzed whole
blood was collected and stained per the manufacture’s protocol (Leinco Technologies).
Whole blood (100 L) was blocked for 20 minutes with FcBlock and rat IgG and then

50

stained with PE-Cy7-F4/80, FITC-Gr-1 and PE-CXCR2. Following staining, erythrocytes
were lysed with 2 mL Easy Lyse Solution (Leinco Technologies) for 11.5 minutes. Lysis
was terminated by addition of 2 mL ice cold Wash Buffer (Leinco Technologies). Cells
were washed twice in flow buffer and resuspended in 500 L flow buffer. Both skin and
blood samples were collected on the FACSCanto I and FACS LSR Fortessa (BD
Bioscience, San Jose, CA) and data were analyzed by FlowJo Software (Tree Star Inc,
Ashland, OR). Fluorescence minus one control staining and single color controls were
used to determine positive staining.

Phagocytosis and FcRIII Staining
Following isolation, wound cells were subjected to pHrodo-S. aureus phagocytosis as
previously described (177). Cells were resuspended to 1x106 cells/mL in Phagocytosis
Uptake Buffer (Hank’s balanced salt solution (HBSS; Gibco, Grand Island, NY), with 20
mM HEPES, pH 7.4) per the manufacturer’s instructions (Invitrogen, Carlsbad, CA).
pHrodo-S. aureus BioParticles (Invitrogen, Carlsbad, CA) were reconstituted to 1
mg/mL in Phagocytosis Uptake Buffer and then opsonized with rabbit polyclonal IgG
antibodies (Invitrogen, Carlsbad, CA) for 1 hour at 37oC. Control tubes for each animal
were placed on ice (4oC) and experimental tubes placed at 37oC for 15 minutes to allow
for temperature equilibration. pHrodo-S. aureus was then added at a ratio of 30:1 bacteria
particles to cell. Samples were incubated for 0-60 minutes at 4oC (control) or 37oC
(experimental) after which phagocytosis was stopped by addition of 2 mL ice cold
Phagocytosis Uptake Buffer and placement on ice. Cells were blocked with rat IgG and
anti-FcRII (R&D Systems, Minneapolis, MN), to block FcRI and FcRII, respectively,
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for 20 minutes at 4 C. Samples were then stained with PE-anti-FcRIII (R&D Systems,
Minneapolis, MN) for 30 minutes followed PE-Cy7-anti-F4/80 and FITC-anti-Gr1 for 30
minutes at 4oC (178). Cells were washed twice, resuspended in flow buffer, and
phagocytosis and FcRIII expression on wound neutrophils and macrophages were
examined by flow cytometry. Data were acquired on the FACSCanto1 (BD Bioscience,
San Jose, CA) and analyzed by FlowJo Software (Tree Star Inc, Ashland, OR).

Peripheral Blood Neutrophil Isolation and Bactericidal Assay
Heparinized whole blood was collected from unmanipulated animals and neutrophils
sorted on the FACSAria. Briefly, 500-700uL heparinized blood was lysed according to
the manufacturer’s instructions (Leinco Technologies). Cells were washed twice and
resuspended in flow buffer. Cells were sorted based on forward (FSC) and side (SSC)
scatter. Cytospins and Diff Quick staining of sorted cells were used to confirm purity by
morphology. Sorted cells were evaluated for bactericidal activity as previously described
with some modifications (179). Neutrophils were seeded at 105 cells onto poly-L-lysine
coverslips for 1 hour at 37oC. S. aureus Newman was grown overnight in TSB,
resuspended to 106 CFU/mL in TSB and opsonized with 5% normal mouse serum in
HBSS for 30 minutes at 37oC. Coverslips with incubated with bacteria (10:1 ratio of
bacteria: cells) in HBSS for 15 minutes under agitation to allow phagocytosis to occur.
Phagocytosis was stopped by placing coverslips in ice cold HBSS and washing three
times. One coverslip was then lysed with ice cold ddH20 for 5 minutes. Lysates and 10fold serial dilutions of lysates were plated on MSA plated for 24-48 hours to determine
the amount of bacteria phagocytosed. The remaining coverslips were placed in HBSS for
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45 or 75 minutes at 37 C to allow bactericidal activity to occur. At either 45 or 75
minutes, coverslips were lysed with ice cold ddH20. Lysates and 10-fold serial dilutions
of lysates were plated on MSA and incubated at 37oC for 24-48 hours. Bacterial growth
was determined by colony counts. Bactericidal activity (percent killing) was determined
by: (number of colonies remaining at either 45 or 75 minutes/number of colonies initially
present after the phagocytosis phase)*100.

Chemokine Analysis
One wound was homogenized in 1mL BioRad Cell Lysis buffer (BioRad, Hercules, CA)
supplemented with Factor 1, Factor 2 and PMSF per the manufacturer’s instructions
(BioRad, Hercules, CA). Homogenates were sonicated at 30%, syringeand chemokines (KC, MIP-2 and MCP-1) were analyzed by ELISA (R&D Systems,
Minneapolis, MN) (180).

In Vivo Chemotaxis
Young and aged mice were administered 100 mg/kg ketamine and 10 mg/kg xylazine
followed by saline to ensure systemic distribution of the anesthetic. Once the mice no
longer responded to firm pressure applied to their hind limb, their dorsum’s were shaved
and cleansed with ethanol pads. In the dorsal subscapular midline, mice received
subcutaneous (s.c.) injections of 100 or 1000 pg of recombinant mouse KC in a volume
of 50 L or saline vehicle (50 L). Mice were sacrificed 8 hours after injections. The
injection site and surrounding tissue were excised with an 8 mm punch biopsy and
subjected to digestion as outlined above (177). Neutrophil recruitment to the injection site
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was evaluated by flow cytometry as described above. Data are expressed as fold change
of baseline neutrophil recruitment after saline injections.

Statistical analysis
Data are shown as mean ± standard error of the mean (SEM) of each group. Data were
analyzed by Student’s t test or one- way or two-way ANOVA with Tukey’s or Bonferroni
post-hoc tests, respectively, where appropriate using GraphPad Prism 5 (GraphPad, La
Jolla, CA). A value of p ≤0.05 was considered significant.
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Results
Bacterial colonization and wound closure is impaired with advanced age.
To evaluate the impact of advanced age on the innate immune response following
cutaneous injury and S. aureus infection, we developed a model of cutaneous wound
infection in young and aged mice to evaluate bacterial colonization and wound size at
days 1, 3, 7 and 10 after injury and infection (Figure 5). Bacterial colonization in wounds
from aged mice were elevated over the time course examined as compared to young
mice, with post-hoc significance observed at day 3 (Figure 6, p<0.05). Levels of wound
bacterial burden were unaltered in aged animals at day 7 as compared to day 3, whereas
gradual reduction in wound bacterial content was observed in young animals by day 7.
Moreover, by day 10, wounds from young mice averaged 103 CFU/mL, compared to 106
CFU/mL in aged animals.

Interaction: 0.0694
Age: 0.0002
Time: 0.0020
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Young

S. aureus (log CFU/mL)

10 8

*
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Young

10 6

Aged

10 5
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10 3
10 2
1

3
7
Days Post Injury and Infection

10

*p<0.001 compared to young at same time point by
Figure 6. Wound bacterial colonization at days 1 through 10 following cutaneous
two-way ANOVA. Data shown as mean + SEM, n=8-20
injury and S. aureus infection. Young BALB/c (3-4 months, black circles and solid
line) and aged Balb/C (18-20 months, black squares and dotted line) received six, 3mm
dorsal cutaneous wounds followed by ~103 CFU S. aureus/wound. At days 1, 3, 7 and 10
after injury and infection, mice were sacrificed and bacterial colonization was determined
by growth on MSA plates. Data are shown on a log scale as mean ± SEM, *p<0.001
compared to young at same time point by two-way ANOVA; N=8-20 per group at each
time point.
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In parallel to these studies, wound size was evaluated by digital photography and
image analysis. Compared to young mice, wounds from aged mice had a larger percent
open wound area remaining at days 3 and 7 following injury and infection (Figure 7,
p<0.05), with incomplete closure at day 10. At day 3, wounds in aged animals remained
~80% open as compared to ~66% in young mice (Figure 7B, p<0.05). By day, an ~ 2fold increase in percent open wound area was observed in aged mice as compared to
young (Figure 7B, p<0.05). The persistent open wound bed at day 10 in aged animals
(~11% versus ~0.9% in young mice) could result in subsequent infectious complications
in aged mice. Together, these findings recapitulate clinical observations of increased
infectious complications and delayed healing with advanced age.
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(A) group
Representative images of wound from young (top panel) and aged
n=7-15 per
(bottom panel) mice are days 1, 3, 7, and 10 after injury and infection. (B) Wound size
expressed as percent open wound area relative to time zero at days 1, 3, 7 and 10 after
cutaneous wound infection in young (black circle and solid line) and aged (black squares
and dotted line) mice. Data are shown as mean ± SEM, **p<0.01 and *p<0.05 compared
to young at same time point by two-way ANOVA; N=7-15 per group.
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Host recognition is not altered following injury and infection
Previous studies have reported decreased TLR expression in various innate
immune cell subsets with advanced age (reviewed in (3, 161)). TLR-1, -2 and -6 play
critical roles in early host recognition of Gram-positive pathogens, and loss of TLR2 or
downstream mediators of TLR signaling, such as MyD88, results in increased
susceptibility to S. aureus infection (98, 181-183). Given differences in bacterial
colonization at day 3, we chose to evaluate TLR2 expression on resident tissue
macrophages (F4/80+Gr-1- cells from uninjured skin) as well as on infiltrating wound
leukocytes in aged mice relative to young (Figure 8). In aged mice, a reduction in the
absolute number of TLR2+ resident tissue macrophages (Figure 8B, p<0.05) was
observed compared to young mice. Following injury and infection, there were no agedependent changes in the frequency of TLR2+ infiltrating macrophages and neutrophils
(Figure 8C-D). Moreover, aging did not alter the expression of TLR2 on infiltrating
leukocytes after injury and infection (Table 1). The changes in number of TLR2+ resident
tissue macrophages with age may increase susceptibility to infection; however, following
injury and infection, TLR2 expression did not contribute to prolonged bacterial infection
in aged animals.
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Figure 8. Expression of TLR2 by cutaneous neutrophils and macrophages. The
number of neutrophils or macrophages expressing TLR2 was examined by flow
cytometry. (A) Gating strategy for TLR2+ resident and infiltrating leukocytes. Live cells

Young
Aged

60
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+

-

were gated on Gr-1 and F4/80; F4/80 Gr-1 (neutrophils), F4/80 Gr-1 (macrophages).
Neutrophil and macrophage populations were then evaluated for TLR2 positivity (dotted
black line). (B) Absolute number of TLR2+ macrophages in uninjured skin from young
and aged mice, *p<0.02 by Student’s t-test, N=7 per group. (C) Frequency of TLR2+
wound macrophages at day 1 and day 3 in young (gray bars) and aged (white bars) mice.
(D) Frequency of TLR2+ neutrophils at day 1 and day 3 in young and aged mice. Data are
shown as mean + SEM; N=8-17 per group. Data are not significant.

Table I. MFI of TLR2 by cutaneous neutrophils and macrophages.
Macrophages

Neutrophils

(F4/80+/Gr-1-/TLR2+)

(F4/80-/Gr-1+TLR2+)

Uninjured

Day 1

Day 3

Day 1

Day 3

Young

518.7±22.2

678.3±48.1

603.0±17.0

612.1±39.1

451.6±15.9

Aged

586.3± 42.0

627.5±42.3

642.2±41.5

576.0±30.5

441.6±13.2

No difference was observed in the MFI of TLR2 in macrophages isolated from uninjured
skin, or in the MFI of TLR2 in neutrophils or macrophages isolated from infected
wounds. No significant differences between young and aged at each time point were
observed. Data are shown as mean ± SEM; N=7-11 per group.
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Bacterial clearance is not affected by advanced age
In addition to recognition of bacteria by the host immune system, neutrophils and
macrophages that are recruited to the wound site are required to phagocytose and clear
invading organisms. In particular, deficiencies in neutrophil and macrophage
phagocytosis, as well as bactericidal potential, have been associated with reduced
bacterial clearance as well as chronic or repeated infections (43, 46, 120, 184). A major
phagocytic pathway in these cells is the FcR pathway (32). Interestingly, reduced
expression of FcRIII (CD16) and phagocytosis have been observed in neutrophils from
aged humans (46). Similar studies in macrophage populations suggest a reduced
phagocytic potential with advanced age (185-187). Thus, we sought to determine if
differences in phagocytosis and FcRIII expression may contribute to delayed resolution
of bacterial clearance in our model. Initially, we examined FcRIII expression in
peripheral blood neutrophils in our young and aged animals pre- and post-infection. In
line with studies by Butcher et al., there was a reduction in the frequency of FcRIII+
neutrophils in aged mice following injury and infection (Figure 9)(46).

62
A

B
250K

105

103

100K

102

50K

0

0
0

10
<APC-A>: CD16

<APC-A>: CD16

105

5

104

104

10

0 102

50K 100K 150K 200K 250K
FSC-H

3

10

102

0

0
103
104
<FITC-A>: GR1

105

0 102

103
104
<FITC-A>: GR1

75
50

105

3

102

0 102

103
104
<FITC-A>: GR1

100

25
0

CD16+ Peripheral Blood
Neutrophils (%)

SSC-A

10

150K

Young
Aged

4

CD16+ Peripheral Blood
Neutrophils (%)

<PE-Cy7-A>: F480

200K

100

*

*

75
50
25

Sham

0
Wound
Sham

Wound
Infection

Wound
Infection

105

Figure 9. Expression of FcRIII by peripheral blood neutrophils after injury and
infection. Peripheral blood cells were stained for FcRIII expression by flow cytometry.
(A) Gating of FcRIII+ neutrophil population (F4/80-Gr-1+FcRIII+). (B) Percentage of
peripheral blood neutrophils expressing FcRIII in young (gray bars) and aged (white
bars) mice. Data are shown as mean + SEM, *p<0.05 by one-way ANOVA with Tukey’s
t-test; N=3-4 per group.
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Butcher et al. had documented that reduced FcRIII expression was associated with
reduce phagocytic potential in neutrophils isolated from the periphery of elderly subjects
(46). Interestingly, few studies have examined the impact of the wound
microenvironment on phagocytic cell function in the setting of advanced age. Given these
data, we examined the phagocytic potential and the expression of FcRIII pre- and postphagocytosis in wound cells isolated from young and aged mice. Phagocytosis of
pHrodo-S. aureus bioparticles by wound neutrophils were not different in young and
aged mice (Figure 10A-B). Despite no observed changes in phagocytosis, there were
fewer FcRIII+ neutrophils pre- and post- phagocytosis in aged animals and the MFI of
FcRIII was diminished (Figure 10C-D, p<0.05).
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Figure 10. Wound neutrophil phagocytosis of S. aureus and FcRIII expression.
Wound leukocyte suspensions were allowed to phagocytose pHrodo-S. aureus particles
for 0-60 minutes and then stained for FcRIII expression. Phagocytosis and FcRIII were
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assayed by flow cytometry. (A) Representative histograms (shaded gray-4 C, control;
black-37oC, 30 minutes; and black dotted-37oC, 60 minutes) of phagocytosis by wound
neutrophils (F4/80-Gr-1+S. aureus+). (B) Percentage of wound neutrophils that
phagocytosed pHrodo-S. aureus particles in young (gray bars) and aged (white bars)
mice. Data are not significantly different. (C) Percentage of wound neutrophils
expressing FcRIII in young and aged mice; *p<0.05 versus young control, ‡p<0.001
versus young phagocytosis, §p<0.05 versus young and aged controls by one-way
ANOVA. (D) MFI of FcRIII on wound neutrophils from young and aged mice;
§p<0.001 versus young control, ‡p<0.001 versus young control and
phagocytosis,*p<0.001 versus aged matched control by one-way ANOVA. Data are
shown as mean + SEM; N=9-12 per group for phagocytosis assays and N=4-8 for FcRIII
studies.
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Similar to these findings, no age-dependent changes in phagocytosis by wound
macrophages were observed (Figure 11A-B). In both young and aged mice, the
frequency of FcRIIIhi macrophages was reduced post-phagocytosis as compared to cells
from age-matched controls (Figure 11C, p<0.05). However, there were no age-dependent
differences in the frequency of total FcRIII+ macrophages between young and aged
mice pre- or post-phagocytosis (Figure 11C). Moreover, there was a reduction in the
MFI of FcRIII in aged mice compared to young regardless of exposure to pHrodo-S.
aureus (Figure 11D, p<0.05).
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Figure 11. Wound macrophage phagocytosis of S. aureus and FcRIII expression.
Wound leukocyte suspensions were allowed to phagocytose pHrodo-S. aureus particles
for 0-60 minutes and then stained for FcRIII expression. Phagocytosis and FcRIII were
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assayed by flow cytometry. (A) Representative histograms (shaded gray-4 C, control;
black-37oC, 30 minutes; and black dotted-37oC, 60 minutes) of phagocytosis by wound
macrophages (F4/80+Gr-1-S. aureus+). (B) Percentage of wound macrophages that
phagocytosed pHrodo-S. aureus particles in young (gray bars) and aged (white bars)
mice. Data are not significant. (C) Percentage of wound macrophages expressing FcRIII
in young and aged mice; *p<0.05 versus young control, ‡p<0.01 versus aged control by
one-way ANOVA. (D) MFI of FcRIII on wound macrophages from young and aged
mice; ‡p<0.01 versus young control,*p<0.05 versus young phagocytosis, §p<0.05 versus
aged control by one-way ANOVA. Data are shown as mean + SEM; N=9-12 per group
for phagocytosis assays and N=4-8 for FcRIII studies. *p<0.05 versus young control,
§p<0.05 versus young control and young phagocytosis, ‡p<0.05 versus age control.
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Though age did not impact the phagocytic potential of isolated wound neutrophils or
macrophages ex vivo, decreased FcR expression has been shown to play a role in
bactericidal activity via Rac-2 mediated formation of the NADPH oxidase complex (32,
42). To evaluate if the observed reduction in FcRIII impaired the ability of neutrophils
to kill ingested organism, isolated peripheral blood neutrophils were subjected to a
modified bactericidal assay (179). Neutrophils were allowed to phagocytose opsonized
pHrodo-S. aureus for 15 minutes, and percent killing of ingested bacteria was evaluated
at 45 and 75 minutes after the end of the phagocytosis phase. No age-related differences
in bactericidal activity were observed at either time point (Figure 12).
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Figure 12. Bactericidal activity of peripheral blood neutrophils. Peripheral blood
neutrophils were sorted from whole blood based on FSC and SSC via the FACSAria (A).
(B) Cytospin of the sorted neutrophil population. hours to determine the amount of
bacteria phagocytosed. Bactericidal activity (percent killing) was determined by:
(number of colonies remaining at either 45 or 75 minutes/number of colonies initially
present after the phagocytosis phase)*100. Bactericidal activity at 45 minutes (C) and 75
minutes (D). Data are shown as a scatter plot with mean + SEM; N=5-6 per group. Data
are not significantly different.
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Peak leukocyte infiltration is attenuated in aged mice
As differences in host recognition, phagocytosis and bactericidal activity did not
seem to contribute to delayed resolution of bacterial wound infection in aged animals, we
hypothesized that age impairs the recruitment of leukocytes to the infected wound bed.
Previous studies have documented that advanced age can alter the inflammatory cell
infiltrate in non-infected wounds of aged mice (49, 50); however, the impact of cutaneous
infection on leukocyte recruitment with age has not been examined. Wound leukocyte
recruitment was assayed by flow cytometry at days 1-10 after injury and infection
(Figure 13). At day 1, a similar number of wound neutrophils and macrophages were
observed in young and aged mice (Figure 13A-B). However, at day 3, there was a
reduction in neutrophil and macrophage numbers isolated from wounds from aged mice.
(Figure 13A-B, p<0.05). Numbers of wound neutrophils and macrophages were
comparable in young and aged mice at day 7, despite persistent infection in aged animals.
No difference in T cell recruitment was noted at any time point (Figure 13C). The delay
in neutrophil and macrophage recruitment at day 3 in aged animals may impair early
bacterial clearance while the inability to recruit elevated numbers of leukocytes in aged
mice at later time points may contribute to the persistent infection observed in these
animals. Moreover, this altered leukocyte recruitment may perturb wound healing
kinetics, delaying transition from the inflammatory to the proliferative phase and
ultimately impairing wound closure and restoration of the dermal matrix.
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bars) and aged (white bars) was assessed by flow cytometry at days 1 through 10 post
cutaneous wound infection. (A) Gating strategy for wound neutrophils (F4/80-/Gr-1+),
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Enhanced chemokine secretion in wounds from aged animals
Important to neutrophil and macrophage recruitment are the chemotatic stimuli
generated following tissue injury by keratinocyte and resident tissue leukocytes (128,
188). To determine if the decreased neutrophil and macrophage numbers were due to
reduced chemoattractant production, we evaluated the wound chemokine milieu.
Interestingly, at day 1 following injury and infection, wounds from aged mice had
elevated levels of KC and MIP-2, potent neutrophil chemokines and the murine
homologs of human IL-8 (Figure 14A-B, p<0.05). Furthermore, wounds from aged mice
had increased levels of MCP-1, a chemokine that helps recruit and differentiate
circulating monocytes (Figure 14C, p<0.05). However, these elevated levels of
neutrophil and macrophage chemokines were associated with similar neutrophil and
macrophage recruitment at day 1. At day 3, when neutrophil and macrophage numbers
were significantly reduced in aged animals, levels of these three chemotatic mediators
were similar in young and aged mice (Figure 14, p<0.05). These data suggest that aged
mice may require a stronger chemotatic stimulus at the site of injury and infection to
generate recruitment of a similar number of infiltrating leukocytes.
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levels in wounds of young (black circles and

solid line) and aged (black squares and dotted line) mice present at the site of wound
infection were measured by ELISA. (A) KC, *p<0.0001 compared to young at same time
point by two-way ANOVA. (B) Macrophage inflammatory protein-2 (MIP-2), *p<0.05
compared to young at same time point by two-way ANOVA. (C) Macrophage
chemoattractant protein-1 (MCP-1), *p<0.05 compared to young at same time point by
two-way ANOVA. Data are shown as mean + SEM; N=8-22 per group (days 0-3) and
N=3-6 per group (day 7).
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Elevated CXCR2 expression in peripheral blood neutrophils of aged animals following
injury
KC and MIP-2 are ligands for the chemotatic receptor CXCR2 present on
circulating neutrophils (189). Ligation of CXCR2 results in upregulation of selectins and
adhesion molecules which allow neutrophils to roll, adhere and subsequently
transmigrate across endothelial walls to reach the site of injury or infection (26, 28, 190,
191). Considering a strong chemotatic stimulus was present at the wound site in aged
animals, we examined the peripheral neutrophil pool to determine if age-dependent
differences in CXCR2 expression could account for reduced leukocyte recruitment with
age. Following injury and infection at days 1 and 3, the frequency of neutrophils in
circulation was elevated in aged mice compared to young mice at both time points
(Figure 15A-B, p<0.05). There was no difference in the frequency of CXCR2+
neutrophils between young and aged mice prior to or following injury (Figure 15C).
Following cutaneous wound infection, downregulation of CXCR2 expression was
observed in mice of both age groups, however the MFI of CXCR2 on neutrophils from
aged mice was significantly elevated (Figure 15D). This elevation persisted out to day 3,
where CXCR2 expression remained increased in aged mice relative to young mice. These
data suggest that mediators downstream of CXCR2 may contribute to decreased
neutrophil recruitment to the wound site in aged animals.
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expression. Whole blood was analyzed by flow cytometry to determine the percentage of
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strategy for neutrophils in whole blood by flow cytometry. (B) Percentage of circulating

77

neutrophils in peripheral blood in young (gray bars) and aged (white bars) mice. (C)
Frequency of CXCR2+ neutrophils in peripheral blood. (D). Expression of CXCR2 on
peripheral blood neutrophils. Data shown as mean + SEM, N=9-18, *p<0.05 and
**p<0.001 versuss young at same time point by two-way ANOVA.
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Aging impairs in vivo chemotaxis to dorsal cutaneous skin
Reduced neutrophil accumulation in spite of increased CXCR2 expression
coupled with a comparable chemotactic stimulus in aged mice as compared to young
suggests that aging may contribute to a neutrophil migratory defect. Previously, our
laboratory has demonstrated that peripheral blood neutrophils from aged animals
demonstrate a basal hyperchemokinesis with a reduced directional migration toward a
chemotatic stimulus in vitro (60). We extended these findings to determine if reduced
neutrophil numbers in cutaneous infected wounds in aged animals may be due to a
chemotatic deficiency in vivo. Following s.c. injection of 100 pg of KC, neutrophil
recruitment to the dorsal skin in aged mice was reduced as compared to young (Figure
16, p<0.05). To determine if this could be overcome by higher doses of a chemotactic
agent, we evaluated neutrophil recruitment after injection of 1,000 pg of KC. At a tenfold higher dose, aged mice still had impaired neutrophil recruitment as compared to their
younger counterparts given the same dose (Figure 16, p<0.05). However, neutrophil
recruitment in aged mice at a dose of 1000 pg was similar to that observed in young mice
at a dose of 100 pg. These findings parallel our results observed following cutaneous
wound infection in aged mice, suggesting that a higher chemotatic stimulus may be
required to mediate a similar chemotatic response with advanced aged. Together, these
data suggest that reduced neutrophil recruitment to site of cutaneous wound infection
may be due to impaired chemotaxis with advanced age, independent of the level of
chemoattractant stimuli or CXCR2 expression.
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Figure 16. In vivo neutrophil chemotaxis in response to KC. Young and aged mice
were injected s.c. with increasing doses of KC (0, 100 and 1000 pg) and neutrophil
recruitment to the skin was examined by flow cytometry. Data are shown as mean +
SEM, N=3-6 per group, *p<0.05 versuss young at same time point by two-way ANOVA.
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Summary
We developed a murine model of S. aureus cutaneous wound infection that allows
for assessment of age-dependent differences in the innate immune response. In aged
animals, we observed elevated levels of bacteria in wounds at early time points with
active infection to 10 day in aged animals. Our data is in concert will clinical and murine
studies that demonstrate aging is associated with elevated rates of infection (121, 159,
174, 192). Furthermore, we are the first to demonstrate that wound closure was delayed
in aged animals as compared to young following S. aureus wound infection. Again, these
studies are in-line with aging mouse studies that report decreased wound healing in
aseptic wound models (49, 63).
We evaluated several parameters of the innate immune response to determine
what may be contributing to these age-associated differences in bacterial burden and
wound healing. First, we examine TLR2, a PRR responsible for initiating immune
responses to Gram-positive bacteria. While we observed a reduction in TLR2 expression
in resident tissue macrophages from uninjured skin in aged mice, these age-related
differences were not observed in infiltrating leukocytes at days 1 and 3 after injury and
infection. These data suggest that diminished TLR2 levels in resident macrophages may
play a role in heightened susceptibility to infection with age; however, alterations in
TLR2 likely do not contribute to delayed resolution of wound infection in aged animals.
While some groups have reported that aging negatively impacts a variety of TLRs (74),
others demonstrate no impact of age on TLR expression in a variety of cell subsets (74,
101, 192). These reports suggest that the effect of age on TLR expression or function
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may be cell type or model dependent, and future work to clarify the impact of age on
TLR function needs to be conducted in clinical relevant models.
Another critical neutrophil and macrophage function is phagocytosis and killing
of foreign pathogens. Previous studies have reported that aging negatively impacts
neutrophil and macrophage phagocytosis (46, 50, 120, 185, 186), though few have
evaluated the phagocytic potential of leukocytes following recruitment in response to
tissue injury. In our model of wound infection, no age-dependent differences in wound
neutrophil or macrophage phagocytosis were noted. Downstream of FcR activation, the
small GTPase Rac2 plays an essential role in assembly and recruitment of the NADPH
oxidase complex to the phagosome to mediate bactericidal activity (32, 42). Despite
reduction of FcR levels in aged animals, no difference in bactericidal activity was
observed. While other Fc receptors and phagocytic pathways were not examined, our data
imply that age does not impair Fc-mediated phagocytosis in wound neutrophils or
macrophages.
Most appreciably, we observed delayed recruitment of neutrophils and
macrophages to the site of wound infection in aged animals as compared to young.
Alterations in infiltration of these cells can impact several facets of wound healing. For
example, reduced phagocyte recruitment may impair bacterial clearance and promote
infectious spread (193). Moreover, studies in aging models have suggested requirement
for neutrophils in successful wound healing with advanced age (49). Increasing
neutrophil numbers via G-CSF administration enhanced rates of wound closure in aged
mice to those observed in young mice (49). In the context of an infected wound, the need
for neutrophil infiltration becomes increasingly paramount as patients with reduced
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neutrophil function or numbers are at a heightened risk for chronic and repeated
infections with catalase-positive bacteria, like S. aureus (43, 184, 194). Thus, the
decreased absolute numbers of neutrophils and macrophages in our model may not only
contribute to bacterial colonization differences observed with age, but may also play a
role in delayed wound resolution in aged animals.
As mentioned previously, this weakened neutrophil response may impair
resolution of wound infection in aged mice. Recently, we demonstrated that peripheral
blood neutrophils from unmanipulated young and aged mice have a basal
hyperchemokinesis but lack directional migration ex vivo (60). These studies extend these
findings and show a reduced migratory response to in vivo, s.c. KC in aged mice relative
to young. Interestingly, this impaired recruitment to cutaneous tissues was observed in
spite of elevated CXCR2 expression on circulating neutrophils from aged animals.
Together, these data indicate that signaling downstream of CXCR2 may be altered with
age. Future work to determine the mechanism associated with impaired chemotaxis with
age may translate into therapeutic modalities which can improve resolution of wound
infection in aged animals.

CHAPTER 4
G-CSF ENHANCES RESOLUTION OF STAPHYLOCOCCUS AUREUS WOUND
INFECTION IN AN AGE-DEPENDENT MANNER
Abstract
This study tested the hypothesis that heightened bacterial colonization and delayed
wound closure in aged mice could be attenuated by G-CSF treatment. Previously, we
reported that aged mice had elevated bacterial levels, protracted wound closure and
reduced wound neutrophil accumulation following S. aureus wound infection relative to
young mice. In aseptic wound models, G-CSF treatment improved wound closure in aged
mice to rates observed in young mice. Given these data, our objective was to determine if
G-CSF could restore age-associated differences in wound bacterial burden and closure
and increase wound neutrophil recruitment. Young (3-4 month) and aged (18-20 month)
BALB/c mice received three dorsal, subcutaneous injections of G-CSF (250 pg/50
l/injection) or saline control (50 l/injection) 30 minutes after wound infection. Mice
were sacrificed at days 3 and 7 post wound infection and bacterial colonization, wound
size, wound leukocyte accumulation and peripheral blood were evaluated. At days 3 and
7 after wound infection, bacterial colonization was significantly reduced in G-CSFtreated aged mice to levels observed in saline-treated young animals. Wound size was
reduced in G-CSF-treated aged animals, with no affect on wound size in G-CSF-treated
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young mice. Local G-CSF treatment significantly enhanced neutrophil wound
accumulation in aged mice at day 3 and 7, whereas there was no G-CSF-induced change
in young mice. G-CSF treatment did not significantly impact macrophage or T cell
infiltration at days 3 and 7 in young or aged mice. These data demonstrate that G-CSF
enhances bacterial clearance and wound closure in an age-dependent manner. Moreover,
G-CSF may be of therapeutic potential in the setting of post-operative wound infection or
chronic, non-healing wounds in elderly patients.

Introduction
Chronic, non-healing wounds are estimated to account for over 25 billion dollars
in US health care costs (151). The failure to effectively heal wounds is often compounded
by co-morbidities, such as diabetes or obesity. Another major patient population afflicted
with chronic wounds are the elderly (119, 151, 159). With advanced age, a decline in
immune function elevates rates of wound infection and further impairs wound closure in
these patients (64, 160, 161). In particular, S. aureus infection accounts for 30% of
surgical site infections in healthy, non-aged patients (159). In the elderly, S. aureus
infection jumps to 50%, suggesting a proclivity of this Gram-positive bacterium for the
immunocompromised (159). This increased predilection for infectious complications
raises additional public health concerns, such as prolonged hospital stays, risk for septic
complications or infectious spread in long-term care accommodations. As we continue to
see a precipitous rise in the aged population, the number of total patients affected by nonhealing wounds is expected to rise from the estimated 6.5 million (151). Moreover,
despite investment in antibiotic development for multi-drug resistant bacterial strains,
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these bacteria continually evolve to evade our treatment options (195). New therapeutic
targets that harness the host immune system to help eradicate infection and promote
efficient wound healing will be necessary to decrease the public health cost due to
chronic wounds and wound infection (184).
Despite the knowledge that aging impairs wound healing, little has been done to
determine how the early innate immune response is altered with age in the setting of
wound infection. Models of aging and wound healing have shown alteration in the innate
immune response during the early inflammatory phased of wound healing, as well as
perturbations in mediators of the proliferative and remodeling stages (50, 63, 196-199).
To evaluate how age negatively impacts the innate immune response to cutaneous wound
infection, we previously developed a model of cutaneous wound injury and S. aureus
infection in young and aged BALB/c mice. In this model, aged mice had heightened
levels of bacterial colonization and delayed wound closure as compared to young
animals. These findings were associated with reduced neutrophil recruitment to the
wound site, despite elevated chemokine levels and adequate peripheral blood neutrophil
CXCR2 expression. Moreover, we saw diminished neutrophil chemotaxis to the skin
following subcutaneous injections of the murine neutrophil chemoattractant KC. Others
have demonstrated that addition of G-CSF to their model of aseptic wound healing
enhanced wound closure in aged animals (49), and that G-CSF can restore defects in ageassociated neutrophil chemotaxis (200). Herein, we are the first to demonstrate that local
administration of G-CSF reduced bacterial colonization and enhanced wound closure in
aged animals via increased neutrophil recruitment at early time points. These data suggest
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that local G-CSF treatment may serve as a potential therapeutic intervention in elderly
patients with wound infections.

Materials and Methods
Animal Model of Cutaneous Injury and Infection
Young (3-4 month) and aged (18-20 month) BALB/c mice (Charles River/NIA,
Kingston Facility, Stony Ridge, NY) were used to determine if local, subcutaneous (s.c.)
G-CSF treatment could restore age-dependent differences to S. aureus wound infection
(Figure 17). All animal studies were approved and performed with strict accordance to
the regulations established by the Loyola University Chicago Animal Care and Use
Committee. Following acclimation at Loyola’s Animal Care Facility, young and aged
mice were subjected to dorsal excisional cutaneous injury as previously described (175).
Briefly, mice were given 10 mg/kg xylazine and 100 mg/kg ketamine intraperitoneal
(i.p.) followed by i.p. saline to ensure systemic distribution of the anesthetic. Dorsal skin
of the mice was placed over a hockey puck, and mice were subjected to 3 sets of 2, 3 mm
dermal punch wounds (Acuderm, Ft. Lauderdale, FL) for a total of 6 dorsal full-thickness
cutaneous wounds. Immediately after injury, mice received ~103 CFU of S. aureus/10 L
of saline and were returned to their cages on heating pads. At 30 minutes after injury and
infection, animals received three s.c. G-CSF injections (250 pg/50 l/injection; R&D
Systems, Minneapolis, MN) or saline vehicle injections (50 l/injection) in the dorsal
midline in between each set of wounds. As sepsis is known to negative impact wound
healing, a low bacterial inoculum was used to limit the risk of systemic dissemination of
bacteria (176). S. aureus Newman strain was grown overnight in TSB at 37oC under
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constant agitation. The next day, 1 mL of the overnight culture was resuspended in 2mL
fresh TSB and incubated at 37oC for 2 hours to ensure mid-logarithmic growth at the time
of application to cutaneous wounds. Absorbance at 600 nm was used to determine the
bacterial concentration (CFU/mL) and the final inoculum was confirmed by back-plating
on MSA (BD Diagnostics, Sparks, MD).
Mice were sacrificed at days 3 and 7 after injury and infection. The pelt was
removed and photographed to measure wound size as described below. A larger 5 mm
punch biopsy was used to remove the 3 mm wounds. Wounds were examined for
bacterial colonization and flow cytometric analysis of wound immune infiltrate (Brubaker
et. al 2012, manuscript submitted). Heparinized whole blood was obtained via cardiac
puncture for flow cytometric analysis (Brubaker et. al 2012, manuscript submitted).
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Figure 17. Model of S. aureus cutaneous wound infection +/- G-CSF treatment in
young and aged mice. Young (3-4 month) and aged (18-20 month) BALB/c mice were
anesthetized and their dorsum shaved. Mice then received 6, 3 mm dorsal punch wound
followed by ~103 CFU of S. aureus per wound. Saline or G-CSF was administered 30
minutes after injury and infection. Mice were sacrificed at days 3 and 7. Wounds were
assessed for bacterial colonization, wound size and inflammatory cell infiltrate. The
peripheral blood was harvested for evaluation by flow cytometry.
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Bacterial Colonization
One skin wound was homogenized in 1 mL sterile PBS (Gibco, Grand Island,
NY) and 10-fold serial dilutions to 106 were plated on MSA plates (BD Diagnostics,
Sparks, MD). Plates were incubated for 24-48 hours at 37oC and colonies were counted to
determine levels of bacterial colonization (Brubaker et. al 2012, manuscript submitted).

Wound Size
Wound size was evaluated by digital photography and image analysis as
previously described (175). At days 3 and 7 wounds were photographed with a Canon
EOS SLR digital camera. Each pelt was placed flat on a hockey puck and photographed
at a fixed distance of 20 cm with a ruler placed within the frame of each photograph.
Photoshop 7.0 (Adobe Systems Inc., San Jose, CA) was used to determine the number of
pixels in the open wound area using the magic wand tool, with a tolerance setting of 60
and zoom at 100%. Separate animals were sacrificed immediately following wound
injury and wound size was determined to represent day 0. Wound areas at each time point
were compared with day 0 wounds: (pixels at days1-10/pixels at day 0)x100 were used to
determine the percent open wound area at each time point.

Skin Cell Isolation and Flow Cytometry
Single cell suspensions of wound cells for flow cytometry were generated as
previously described (177). At days 3 and 7 after injury and infection, animals were
euthanized, pelts removed and wounds excised using a 5 mm punch biopsy. Two diced
wounds were incubated overnight at 4oC in RPMI 1640 culture media (Gibco, Grand
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Island, NY) containing 10% FBS (Hyclone, Logan, UT), 2 mM L-glutamine (Gibco,
Grand Island, NY), 1% penicillin/streptomycin (Gibco, Grand Island, NY), 2 mg
gentamycin sulfate (Mediatech Inc, Manassas, VA) and 0.3 mg dispase II (Roche
Diagnostics, Indianapolis, IN). Tissue pieces were then removed and subjected to further
enzymatic digestion with 1 mg collagenase from Clostridium histolyticum type 1A
(Sigma-Aldrich, St. Louis, MO), 1.2 mg DNAse I from bovine pancreas Grade II (Roche
Diagnostics, Indianapolis, IN), 1 mg hyaluronidase from bovine testes type 1-S (SigmaAldrich, St. Louis, MO), in RPMI 1640 with 5% FBS, 2 mM L-glutamine, 1%
penicillin/streptomycin, gentamycin and magnesium chloride hexahydtrate for 2 hours at
37oC. After two hours, these solutions were combined and adherent cells were treated
with Accutase (eBioscience, San Diego, CA) for 8 minutes at 37oC followed by vigorous
pipetting. Single cells suspensions were filtered through at 70 m filter to remove debris.
Cells were washed and adjusted to 1x106/mL. Wound cells were blocked for 20 minutes
with FcBlock (anti-CD16/CD32, eBioscience) and rat IgG (Jackson ImmunoResearch,
West Grove, PA), and then stained with PE-Cy7-F4/80 (eBioscience, San Diego, CA),
FITC-Gr-1 (eBioscience, San Diego, CA) and APC-CD3 (eBioscience, San Diego, CA).
Cells were washed twice and then resuspended in flow buffer (1% BSA (Sigma-Aldrich,
St. Louis, MO), 0.1% sodium azide and 2mM EDTA in PBS). Events were collected on
the FACS LSR Fortessa (BD Biosciences, San Jose, CA) and data were analyzed by
FlowJo Software (Tree Star Inc, Ashland, OR). Fluorescence minus one control staining
and single color controls were used to determine positive staining. F4/80+Gr-1- cells were
considered macrophages, F4/80-Gr-1+ cells were considered neutrophils and CD3+ cells
were considered T cells.
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Blood Flow Cytometry
Heparinized whole blood was collected and stained per the manufacture’s
protocol (Leinco Technologies, St. Louis, MO). 100 L whole blood was blocked for 20
minutes with FcBlock and rat IgG and then stained with PE-Cy7-F4/80, FITC-Gr-1 and
PE-CXCR2 (R&D Systems, Minneapolis, MN). Erythrocytes were then lysed with 2 mL
Easy Lyse Solution (Leinco Technologies, St. Louis, MO) for 11.5 minutes. Lysis was
stopped by addition of 2 mL ice cold Wash Buffer (Leinco Technologies, St. Louis, MO)
and placement on ice. Cells were washed twice and resuspended in 500 L flow buffer.
Events were collected on the FACS LSR Fortessa (BD Biosciences, San Jose, CA) and
data were analyzed by FlowJo Software (Tree Star Inc, Ashland, OR). Fluorescence
minus one control staining and single color controls were used to determine positive
staining. F4/80-Gr-1+ cells were considered peripheral blood neutrophils.

Statistical analysis
Data are shown as mean ± SEM of each group. Data were analyzed by Student’s t
test or one-way ANOVA with Tukey’s post-hoc tests where appropriate using GraphPad
Prism 5 (GraphPad, La Jolla, CA). A value of p ≤0.05 was considered significant.
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Results
Local G-CSF treatment improves resolution of bacterial infection and wound closure in
aged mice
Previously, we demonstrated that aged mice exhibited elevated bacterial
colonization following cutaneous S. aureus wound infection that correlated with reduced
neutrophil recruitment (Brubaker et. al 2012, manuscript submitted). G-CSF has been
shown to enhance neutrophil recruitment and improve wound closure in aged animals
(49), as well as restore age-associated chemotatic defects (200). Thus, we chose to
investigate if G-CSF could restore bacterial clearance in aged mice by enhancing wound
leukocyte recruitment. Following G-CSF administration, we saw a 75% decrease in
bacterial colonization at day 3 in aged mice as compared to aged, saline control animals
(Figure 18A, p<0.05). At day 3, G-CSF did not affect wound bacterial levels in young
mice. These differences in wound S. aureus colonization persisted out to day 7 with a
97% reduction in bacterial growth in aged animals administered G-CSF compared to
aged-saline control (Figure 18B, p<0.05). While a mild elevation in day 7 wound
bacterial levels in G-CSF-treated young mice was observed, this difference was not
statistically significant from young saline.

93

A

25.0

S. aureus (CFU/mL * 10-6)

Young
Aged

Day 3

20.0

15.0
10.0

**
5.0
0.0
Saline

B
S. aureus (CFU/mL * 10 -5)

1000.0

*

G-CSF

Day 7

100.0

**

**

10.0
1.0
0.1

Saline

G-CSF

Figure 18. Local G-CSF treatment reduces bacterial colonization in aged mice.
Young BALB/c (3-4 month, gray bars) and aged BALB/c (18-20 month, white bars)
received six, 3 mm dorsal cutaneous wounds followed by ~103 CFU S. aureus/wound. 30
minutes after injury and infection, mice either received s.c. G-CSF injections (250 ng/50
l/injection) or saline vehicle injections (50 l/injection). At days 3 (A) and 7 (B), mice
were sacrificed and bacterial colonization was determined by growth on MSA plates.
Data are shown as mean ± SEM, *p<0.05 compared to young saline and **p<0.01
compared to aged saline by one-way ANOVA; N=7-14 per group.
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In concert with these data, we observed that local injection of G-CSF enhanced wound
closure in aged animals at day 3 compared to aged, saline controls (Figure 19A+B,
p<0.05). At day 7, differences in wound size observed between saline treated young and
aged mice was ameliorated following G-CSF treatment (Figure 19A+C, p<0.05). G-CSF
treatment did not affect that rate of wound closure in young mice at day 3 or 7.
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Figure 19. Treatment with G-CSF abrogates age-associated deficits in wound
closure. (A) Representative images of wound from young (left panel) and aged (right
panel) mice at days 3 (top panel) and 7 (bottom panel) after S. aureus wound infection
with or without G-CSF treatment. Wound size expressed as percent open wound area
relative to time zero at days 3 (B) and 7 (C) after cutaneous wound infection in young
(gray bars) and aged (white bars) mice. Data are shown as mean ± SEM, *p<0.05
compared to young saline, **p<0.01 compared to aged saline and ‡p<0.05 compared to
young G-CSF by one-way ANOVA; N=7-14 per group.
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Wound neutrophil recruitment in aged animals in enhanced by local G-CSF treatment
Given that G-CSF restored bacterial clearance and wound closure in aged mice,
we sought to examine if this correlated with enhanced leukocyte recruitment to the
wound bed (Figure 20A). At day 3 following injury and infection, saline-treated aged
mice had reduced absolute numbers of neutrophil and macrophage accumulation
compared to young, saline treated mice (Figure 20B+C, p<0.5). Treatment with G-CSF
increased neutrophil numbers in aged mice in respect to aged, saline treated animals
(Figure 20B, p<0.05) and neutrophil recruitment was no longer different from young
mice. No differences in neutrophil accumulation in young mice administered saline or GCSF were observed. G-CSF treatment did not impact macrophage recruitment at day 3 in
aged animals (Figure 20C). While a mild reduction in macrophage recruitment in young
animals given G-CSF was observed, these differences were not significant. At day 7, GCSF treatment resulted in protracted neutrophil accumulation of wound in aged animals
as compared to all other groups (Figure 20D). This prolonged neutrophil infiltration may
contribute to the reduced bacterial colonization observed in aged animals. No difference
between wound macrophage accumulation was observed in saline- or G-CSF-treated
young and aged mice (Figure 20E). Wound T cell recruitment at day 3 and 7 was similar
between young and aged mice, and these numbers were not significantly affected by
treatment with G-CSF (Table II).
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Figure 20. Neutrophil accumulation is enhanced in aged mice following G-CSF
treatment. Leukocyte infiltration to the wound and surrounding tissue area was assessed
by flow cytometry at days 3 and 7 following cutaneous wound infection and G-CSF
treatment. (A) Gating strategy for wound neutrophils (F4/80-/Gr-1+), wound macrophages
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(F4/80 /Gr-1 ) and wound T cells (CD3 ) by flow cytometry. Absolute number of wound
neutrophils and macrophages at day 3 (B+C, respectively) and day 7 (D+E, respectively).
Data are shown as mean ± SEM, *p<0.05 compared to young saline, **p<0.01 compared
to aged saline and ‡p<0.05 compared to young G-CSF by one-way ANOVA; N=7-14 per
group.

Table II. Wound T cell numbers in saline and G-CSF treated mice.
Saline

G-CSF

(CD3+)

(CD3+)

Day 3

Day 7

Day 3

Day 7

25194.6 ±

23790.1 ±

23721.5 ±

26215.6 ±

6141.9

2568.1

2247.4

3371.0

26659.8 ±

30960.4 ±

36451.4 ±

39230.1 ±

1563.8

5153.6

4798.5

4814.8

Young

Aged

No differences were observed in number of infiltrating T cells (CD3+) at days 3 and 7
after injury and infection between young and aged mice. T cell numbers were not
significantly affected by treatment with G-CSF. Data are shown as mean ± SEM; N=7-14
per group. Data are not significantly different by one-way ANOVA.
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No-age dependent effects of local G-CSF treatment on circulating leukocytes
To eliminate the possibility that local, s.c. G-CSF was inducing changes in the
peripheral blood pool, we evaluated the frequency of circulating neutrophils in young and
aged mice given saline or G-CSF injections (Figure 21). As reported previously
(Brubaker et. al 2012, manuscript submitted), aged mice exhibited heightened levels of
circulating neutrophils at day 3 compared young mice (Figure 21B, p<0.5), and this was
not altered by G-CSF administration. This age-dependent elevation in the frequency of
peripheral blood neutrophils persisted out to day 7 (Figure 21C, p<0.05). The frequency
of CXCR2+ neutrophils in circulation was mildly increased in aged mice in both
treatment groups at days 3 and 7 compared to young animals (Figure 21D-E, p<0.05).
Again, G-CSF treatment did not impact the age-dependent difference in the frequency of
CXCR2+ neutrophils. Similar to our previous study, aged animals exhibited elevated
expression of CXCR2 at day 3 compared to young animals (Figure 21F, p<0.05), and GCSF did not impact the MFI of CXCR2 in either young or aged mice. No age- or G-CSFdependent differences in CXCR2 expression on circulating neutrophils were observed at
day 7 (Figure 21G).
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Figure 21. Local G-CSF does not alter the circulating neutrophil pool in aged mice.
Whole blood was analyzed by flow cytometry to determine the percentage of circulating
neutrophils and expression of the chemotatic receptor CXCR2. (A) Gating strategy for
neutrophils (F4/80-Gr-1+) in whole blood by flow cytometry. Percentage of circulating
neutrophils in peripheral blood in young (gray bars) and aged (white bars) mice at day 3
(B) and day 7 (C). Frequency of CXCR2+ neutrophils in peripheral blood at day 3 (D)
and day 7 (E). Expression of CXCR2 on peripheral blood neutrophils at day 3 (F) and
day 7 (G). Data are shown as mean ± SEM, *p<0.05 compared to young saline, ‡p<0.05
compared to young G-CSF and §p<0.05 compared to young with the same treatment by
one-way ANOVA; N=7-14 per group.
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Summary
Herein, we have demonstrated that one administration of s.c. G-CSF 30 minutes
following cutaneous wound infection with S. aureus promotes bacterial clearance in an
age-dependent manner. The observed reduction in wound bacterial burden at day 3 and 7
in G-CSF-treated aged mice was associated with increased neutrophil accumulation.
Other laboratories have shown that G-CSF treatment can enhance age-related deficits in
neutrophil chemotaxis. Previously, we have reported that neutrophils from aged mice
demonstrate hyperchemokinesis but impaired directional motility in vitro. In vivo studies
confirmed that neutrophils from aged mice have a reduced migratory response toward s.c.
KC (Brubaker et. al 2012, manuscript submitted). We hypothesize that G-CSF restores
these chemotatic defects in aged mice, enhancing neutrophil recruitment and helping
reduce infection at the wound site in aged mice.
Furthermore, G-CSF enhanced wound closure in aged animals as compared to
young. Reports in aged mice indicate that i.p. G-CSF administration augments neutrophil
recruitment and promotes wound closure in aseptic models of wound healing (49). The
necessity of neutrophils for improved wound healing in these studies was confirmed by
direct application of peritoneal derived neutrophils to the wound site. Together, these data
suggest that neutrophils are required for wound closure in aged mice, and, in the setting
of wound infection, increasing neutrophil recruitment promotes resolution of wound
infection in aged mice.
We did not observe any systemic effects of G-CSF on the peripheral blood pool.
Local, one-dose administration of G-CSF did not significantly enhance the frequency of
circulating neutrophils or the expression of their primary chemotatic receptor CXCR2. As
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the effect of G-CSF appears to be localized to the wound site in our studies, these data
support the potential use of local G-CSF as therapeutic intervention with limited systemic
side effects. Future work to elucidate the mechanism by which G-CSF exerts these agedependent effects will develop our understanding of the aging innate immune system and
may reveal therapeutic potential for G-CSF in the wound care setting.

CHAPTER 5
AGE DOES NOT IMPACT ANTIMICROBIAL PEPTIDE EXPRESSION IN A
MODEL OF CUTANEOUS WOUND INFECTION
Abstract
Antimicrobial peptides are small cationic molecules that are able to promote bacterial
killing via interactions with the bacterial membrane, leading to membrane destabilization
and bacterial lysis. In murine studies, mouse -defensin-3 (mBD3), mBD14, cathelicidin
related antimicrobial peptide (CRAMP) and Reg3 have been shown to possess
bactericidal activity against S. aureus. Considering the growing interest in these
molecules as potential therapeutic targets in the setting of infection, we evaluated the
impact of advanced age on cutaneous AMP expression following S. aureus wound
infection in young (3-4 month) and aged (18-20 month) BALB/c mice. At days 1-10 after
injury and infection, mice were sacrificed and AMP expression was evaluated by RTPCR and immunofluorescence. Age-dependent differences in mRNA levels of mBD3,
mBD14 and CRAMP were variable between studies at day 1, with no age-related
difference being observed at later time points. In three replicate studies, Reg3 was
suppressed in aged animals as compared to young following injury and infection at day 1.
By immunofluorescence, levels of mBD3 expression were low in uninjured skin in young
and aged mice. After injury and infection at day 1, young animals had a marked increase
in mBD3 expression along the wound edge. Aged animals failed to upregulate mBD3
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protein levels as seen by immunofluorescence. TLR2 is a known regulator of AMP
expression and the frequency of TLR2+ cells in aged mice was reduced as compared to
young. There were no observed differences in the frequency of TLR2+ keratinocytes
following injury, or in the MFI of TLR2. These data suggest that age-related differences
in the AMP response are variable in our model of cutaneous S. aureus wound infection.
In particular, levels of mBD3 and mBD14 mRNA are contradictory between studies.
While Reg3 seems to be consistently decreased at the mRNA level in aged mice, further
studies to validate these differences at the protein levels should be considered.

Introduction
The failure to effectively heal wounds is estimated to account for over 25 billion
in US health care costs, and is augmented by the increasing prevalence of diabetes and
obesity (151). The growing elderly population is a major contributor to the elevated
prevalence of these chronic conditions, and they are also a major patient population
afflicted with chronic wounds (119, 151, 159). Moreover, aging is associated with a
precipitous decline in immune function that further compounds the delayed wound
closure and heightened risk of infectious complications in the elderly (64, 160, 161). In
healthy, non-aged patients, S. aureus infection accounts for 30% of surgical site
infections as compared to 50% in aged patients, suggesting a penchant of this Grampositive bacterium for the immunocompromised (159). Antimicrobial peptides, such as
defensins and cathelicidins, are small cationic molecules that are able to promote
bacterial killing via interactions with the bacterial membrane, leading to membrane
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destabilization and bacterial lysis (13). Previously, mouse b-defensin-3 (mBD3), the
homolog to human -defensin 2 (hBD2), and mBD14, the ortholog to hBD3, have been
shown to be induced following injury or infection and to possess bactericidal activity
against S. aureus (15, 16, 134, 137, 201). Cathelicidins, like defensins, have also been
show to play critical roles in wound repair and infection. Namely, loss of CRAMP is
associated with increased susceptibility to infection and delayed wound closure in murine
models. More recently, the Reg family of AMPs are emerging as another important
antimicrobial family at the level of the skin and lung. Within this AMP family, Reg3 is
an AMP that is regulated by IL-22, and is most commonly discussed in the context of gut
homeostasis and bacterial clearance (202, 203). While few publications discuss the role
of the Reg family in skin or any tissue other than the gut, IL-22 has been shown to be a
player in skin inflammation [reviewed in (204)]. Recent data has also implicated Reg3
in methicillin resistant S. aureus (MRSA) pneumonia. Despite the knowledge that these
AMPs are important in wound healing and resolution of infection, to our knowledge the
impact of aging on cutaneous AMPs has not been examined.
As a gram-positive organism, the host response to S. aureus is driven in part by
recognition via the TLR2 pathway in epidermal keratinocytes and innate immune cells
(16, 98, 181, 205-207). Increased susceptibility to S. aureus infection is related to loss of
TLR2 (98) by affecting neutrophil recruitment to the infection site (181) and through
decreased expression of cutaneous AMPs in response to infectious challenge (16, 208). In
addition to evaluating AMP expression, we sought to determine if differences in
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keratinocyte TLR2 expression could contribute to potential age-related differences in
antimicrobial peptide levels.
We examined AMP levels in young and aged mice following cutaneous wound
infection with S. aureus. Levels of mBD3, mBD14 and CRAMP yielded inconclusive
results concerning an age-dependent change in these molecules. However, Reg3 was
consistently suppressed in aged mice after injury and infection as compared to young.
These data suggest that Reg3 levels may be reduced with aging; however, further studies
should be conducted to more conclusively evaluate the impact of age on AMP expression
following injury and infection.

Materials and Methods
Animal Model
3-4 month old (young) and 18-20 month old (aged) BALB/c mice (Charles River/NIA,
Kingston Facility, Stony Ridge, NY) were utilized to determine age-dependent
differences in response to cutaneous wound injury and infection (Figure 5). All animal
studies were approved and performed with strict accordance to the regulations established
by the Loyola University Chicago Animal Care and Use Committee. Following
acclimation at Loyola’s Animal Care Facility, young and aged mice were subjected to
dorsal excisional cutaneous injury as previously described (175). Briefly, mice were
administered 100 mg/kg ketamine and 10 mg/kg xylazine i.p. followed by i.p. saline to
ensure systemic distribution of the anesthetic. Once the mice no longer responded to firm
pressure applied to their hind limb, their dorsum’s were shaved and cleansed with ethanol
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pads. Mice were then subjected to 6 dorsal full-thickness (skin and panniculus carnosa)
cutaneous wounds with a 3 mm dermal punch biopsy (Acuderm, Ft. Lauderdale, FL).
Immediately after injury, mice received ~103 CFU/10uL of S. aureus and were returned
to their cages on heating pads. A low inoculum of bacteria was chosen to prevent sepsis
which is known to negatively impact wound healing (176). S. aureus Newman strain was
grown overnight in TSB at 37oC under constant agitation. The next day, 1 mL of S.
aureus in TSB was resuspended in 2mL fresh TSB and incubated at 37oC for 2 hours to
ensure mid-logarithmic growth at the time of application to cutaneous wounds. Bacterial
concentration (CFU/mL) was determined by absorbance at 600 nm and the final
inoculum confirmed by back-plating on MSA (BD Diagnostics, Sparks, MD).
Mice were sacrificed at days 1, 3, 7 and 10 after injury and infection. Wounds
were excised and examined for AMPs via RT-PCR and immunofluorescence as described
below. Two additional wounds, or two 5 mm punches of uninjured skin, were used to
evaluate keratinocyte expression of TLR2.

RT-PCR
Following sacrifice, one wound was excised with a 5 mm punch biopsy and RNA
was extracted using the Qiagen RNeasy Mini Kit (Qiagen, Valencia, CA). RNA was
quantified using a Nanodrop Spectrophotometer ND-1000 (Thermo Scientific,
Wilmington, DE) and cDNA synthesized using the iScript cDNA Synthesis Kit (BioRad,
Hercules, CA). Quantitative RT-PCR was performed with the Applied Biosystems 7500
Fast Real-Time PCR system, using specific TaqMan Expression Assays (Applied
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Biosystems) for mBD3, mBD14, CRAMP, Reg3γ, K14 and -actin. Values were then
normalized to -actin expression via the ΔΔCT method. For re-expression to K-14, each
data set was normalized to -actin, and then expressed as the normalized gene of interest:
normalized K14.

Immunofluorescence
Following sacrifice, a 5mm punch biopsy was used to removed the injured tissue
and tissue borders. The skin was frozen in OCT, sectioned at 0.7 microns and frozen. At
the time of analysis, slides were thawed overnight at room temperature in a humidified
chamber and then fixed in 4% paraformaldehyde for 15 minutes. Slides were washed 3
times with PBS, blocked with 10% BSA with 3% normal goat serum in PBS for 1 hour
and stained overnight at 4oC with rabbit anti-human mBD2 with known cross-reactivity
to mBD3. The following day, slides were washed 3 times with PBS and stained with goat
anti-rabbit-Alexa-488 for 1 hour. Slides were washed three times in PBS and coversliped
using VECTASHEILD mounting media with DAPI for nuclear staining (Vector
Laboratories, Burlingame, CA). Fluorescent images were captured using a Zeiss Axiovert
200 microscope (Zeiss, Thornwood, NY).

Skin Cell Isolation and Flow Cytometry
Single cell suspensions of wound cells for flow cytometry were generated as
previously described (177). At days 1-10 after injury and infection, animals were
euthanized, pelts removed and wounds excised using a 5 mm punch biopsy. Two diced
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wounds were incubated overnight at 4 C in RPMI 1640 culture media (Gibco, Grand
Island, NY) containing 10% FBS (Hyclone, Logan, UT), 2 mM L-glutamine (Gibco,
Grand Island, NY), 1% penicillin/streptomycin (Gibco, Grand Island, NY), 2 mg
gentamycin sulfate (Mediatech Inc, Manassas, VA) and 0.3 mg dispase II (Roche
Diagnostics, Indianapolis, IN). Tissue pieces were then removed and subjected to further
enzymatic digestion with 1 mg collagenase from Clostridium histolyticum type 1A
(Sigma-Aldrich, St. Louis, MO), 1.2 mg DNAse I from bovine pancreas Grade II (Roche
Diagnostics, Indianapolis, IN), 1 mg hyaluronidase from bovine testes type 1-S (SigmaAldrich, St. Louis, MO), in RPMI 1640 with 5% FBS, 2 mM L-glutamine, 1%
penicillin/streptomycin, gentamycin and magnesium chloride hexahydtrate for 2 hours at
37oC. After two hours, these solutions were combined and adherent cells were treated
with Accutase (eBioscience, San Diego, CA) for 8 minutes at 37oC followed by vigorous
pipetting. Single cells suspensions were filtered through at 70 m filter to remove debris.
Cells were washed and adjusted to 1x106/mL. Wound cells were blocked for 20 minutes
with FcBlock (anti-CD16/CD32, eBioscience) and rat IgG (Jackson ImmunoResearch,
West Grove, PA), and then stained with APC-EpCAM (eBioscience, San Diego, CA),
and PE-TLR2 (eBioscience, San Diego, CA). Cells were washed twice and then
resuspended in flow buffer (1% BSA (Sigma-Aldrich, St. Louis, MO), 0.1% sodium
azide and 2mM EDTA in PBS). Events were collected on the FACS LSR Fortessa (BD
Biosciences, San Jose, CA) and data were analyzed by FlowJo Software (Tree Star Inc,
Ashland, OR). Fluorescence minus one control staining and single color controls were
used to determine positive staining. EpCAM+ cells were considered keratinocytes.
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Statistical analysis
Data are shown as mean ± SEM of each group. Data were analyzed by Student’s t test or
one- way or two-way ANOVA with Tukey’s or Bonferroni post-hoc tests, respectively,
where appropriate using GraphPad Prism 5 (GraphPad, La Jolla, CA). A value of p ≤0.05
was considered significant.
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Results
mRNA levels of cutaneous antimicrobial peptides: mBD3, mBD14 and CRAMP
To evaluate the impact of advanced age on AMP expression following cutaneous
injury and infection, we examined mRNA levels of mBD3, mBD14, CRAMP and Reg3.
Data from our first experiments suggested a lack of induction of mBD3 and 14 at day 1
following injury and infection in aged mice as compared to young, with no age-related
differences noted in mRNA levels of CRAMP (Figure 22A-C). At days 3 and 7 after
injury and infection, there is a trend towards elevated mBD3 mRNA levels in aged mice
as compared to young in two replicate experiments, but these data were not significant.
No consistent difference between age groups were observed for mBD14 at these later
time points (Figure 22D-E).
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Figure 22. Cutaneous antimicrobial peptide expression in young and aged mice
following cutaneous S. aureus infection. Skin was isolated from young (gray bars) and
aged (white bars) mice pre- and post-injury and infection. RNA was isolated from wound
homogenates and gene expression of mBD3, mBD14 and CRAMP were determined by
RT-PCR. (A-C) Relative gene expression of mBD3, mBD14 and/or CRAMP from three
independent experiments in uninjured skin and at day 1 following cutaneous wound
infection. (D-E) Relative gene expression of mBD3 and mBD14 at days 3, 7 and 10 after
injury and infection from two independent experiments. Data are expressed as fold
change compared to young sham and shown as mean ± STDEV (A) or SEM (B-E);
*p<0.05 by Student’s t-test. (A) N=2-3 per group; (B) N=3-5 per group; (C) N=3-4 per
group; (D-E) N=3-6 per group.
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These data suggested a lack of induction of mBD3 and mBD14 at day 1 following injury
and infection in aged mice as compared to young, suggesting a plausible mechanism for
the elevated bacterial colonization and delayed leukocyte recruitment observed in aged
animals. To determine if differences at the mRNA levels translated into differences at the
protein level mBD3 protein expression at day 1 post injury and infection by
immunofluorescence (Figure 23). In intact, uninjured skin obtained from young and aged
sham mice, the levels of mBD3 were very low (Figure 23A-B). At day 1 after cutaneous
wound infection, aged mice demonstrated a lack of induction of mBD3 along the wound
border as compared to young mice (Figure 23C-D). These images are representative of 5
animals per group from the experiment shown in Figure 22B.
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Figure 23. Fluorescent microscopy of mBD3 expression following cutaneous wound
infection in young and aged mice. Uninjured skin and cutaneous wounds excised at day
1 after injury were sectioned, fixed, blocked and then stained overnight at 4oC with rabbit
anti-hBD2. Slides were then incubated with goat anti-rabbit AF488 (green) and DAPI
(blue). Young sham (A), aged sham (B), young wound infection (C) and aged wound
infection (D). Red arrows indicate the wound margin. Note: intense accumulation of
green dye in a circular/oval shape in A-C is associated with hair follicles. Fluorescent
images were acquired on a Zeiss Axiovert 200. Images representative of N=5 animals per
group from the experiment shown in Figure 22B.
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As the relative level of mRNA expression was variable between experiments, an
additional experiment was performed to evaluate mBD3 and mBD14 mRNA levels.
Wounds were analyzed by RT-PCR for mBD3 and mBD14, and in contrast to previous
experiments, mBD3 expression was elevated in aged mice as compared to young (Figure
24A, *p<0.05). No induction of mBD14 was observed, similar to Figure 22C (Figure
24A). After consideration of these data, another experiment with larger animal numbers
was conducted to evaluate mBD3 and mBD14 at day 1 post injury and infection. These
data paralleled the data shown in Figure 24A. At day 1 following cutaneous S. aureus
infection, aged mice demonstrated elevated expression of mBD3 compared to their
younger counter parts (Figure 24B, *p<0.05). While mBD14 was induced in this study,
the relative expression of mBD14 was comparable between young and aged mice (Figure
24B). These data are in vast contrast to the first three studies, and have made it difficult
to determine the role defensins may play in the age-dependent differences observed in
our model.
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Figure 24. Cutaneous antimicrobial peptide expression in young and aged mice,
additional experiments. In two additional replicate experiments, skin was isolated from
young (gray bars) and aged (white bars) mice pre- and post-injury and infection. RNA
was isolated from wound homogenates and gene expression of mBD3 and mBD14 were
determined by RT-PCR (A-B). Data are expressed as fold change compared to young
sham and shown as mean ± SEM; *p<0.05 by Student’s t-test. (A) N=3-6 per group; (B)
N=4-10 per group.
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In an effort to reconcile these divergent data, and to determine the relative amount
of each AMP to keratinocytes in our samples, these data were re-expressed to K14, a
keratinocyte marker (Figure 25). Re-expression of data to K14 did not significantly alter
the trends seen in previous experiments, and suggest to conclusive age-dependent
difference in mBD3 or mBD14 levels. To confirm our protein expression previously
observed by IF, mBD3 and mBD14 ELISAs were purchased to quantify age-dependent
differences. However, these ELISAs failed to develop and similar problems with two
subsequent ELISA kits from this company were noted. Taken together our data remain
inconclusive regarding the expression of mBD3 and mBD14 after cutaneous injury with
advanced age.
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Figure 25. Cutaneous antimicrobial peptide expression relative to K14 in young and
aged mice. Skin was isolated from young (gray bars) and aged (white bars) mice preand post-injury and infection. (A-B) Gene expression of mBD3 and mBD14 re-expressed
relative to K14 and shown as fold change compared to young sham with mean ± SEM;
*p<0.05 by student’s t-test; N=3-5 per group.

Reg3 expression following cutaneous S. aureus wound infection
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Reg3 is another AMP regulated by IL-17 and -22, and has been shown to play a
role in MRSA infection and tissue injury (REFS). Following cutaneous injury and
infection at day 1, we observed a suppression in Reg3 expression in aged animals
relative to young in three replicate experiments (Figure 26, p<0.05). These differences
were maintained after re-expression of the data to K14 (Figure 27). While these studies
suggest that Reg3 mRNA levels may be reduced in aged animals compared to young
following S. aureus wound infection, further work to confirm these studies at the protein
level should be conducted.
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Figure 26. Reg3 gene expression in young and aged mice. Skin was isolated from
young (gray bars) and aged (white bars) mice pre- and post-injury and infection. RNA
was isolated from wound homogenates and gene expression of Reg3 was determined by
RT-PCR. Data are expressed as fold change compared to young sham and shown as mean
± SEM; (A) N= 4-10 per group, **p<0.01 versus young sham, *p<0.05 versus young
wound+infection by one-way ANOVA; (B) N=4-7 per group, *p<0.05 versus young
sham, **p<0.01 versus young wound+infection by one-way ANOVA; (C) *p<0.05
versus young wound+infection by Student’s t-test, N= 2-5 per group.
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Figure 27. Reg3 gene expression relative to K14 in young and aged mice. Skin was
isolated from young (gray bars) and aged (white bars) mice pre- and post-injury and
infection. RNA was isolated from wound homogenates and gene expression of Reg3 and
K14 were determined by RT-PCR. Data are re-expressed relative to K14 and shown as
fold change compared to young sham with mean ± SEM. N= 4-10 per group, **p<0.01
versus young sham, *p<0.05 versus young wound+infection by one-way ANOVA.
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TLR2 and CD14 expression on keratinocytes as regulators of AMP expression
TLR2 is the pattern recognition receptor that aids in recognition of the S. aureus
via homodimerization, or heterodimerization with either TLR1 or TLR6. Binding of S.
aureus to TLR2 results in recruitment of CD14 and initiation of the MyD88 dependent
pathway, resulting in activation of NF-B and the innate immune response (98, 205).
Moreover, TLR2 expression on keratinocytes has been shown to play a role in induction
of defensins (16). Expression of TLR2 on keratinocytes was examined by flow
cytometry (Figure 28A). The epithelial cell population was determined by using the
surface marker epithelial cellular adhesion molecule (EpCAM) (209). The frequency of
EpCAM+ cells did not differ between uninjured young and aged mice (Figure 28B). A
reduction in the frequency of EpCAM+TLR2+ cells found in injured skin from aged mice
was observed (Figure 28C, *p<0.05), though no differences were seen in TLR2
expression between the two age groups prior to injury and infection (Figure 28D).
Following cutaneous wound infection, the frequency of EpCAM+ cells was decreased in
both young and aged animals, however no differences were observed between age groups
(Figure 28E). Similar to uninjured young and aged mice, no age-associated differences
in the frequency of EpCAM+TLR2+ cells or the MFI of TLR2 on EpCAM+TLR2+ cells
were observed (Figure 28F-G).
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Figure 28. Keratinocyte expression of TLR2 pre- and post-cutaneous wound
infection. Expression of TLR2 was determined by flow cytometry with EpCAM+ cells
being considered the keratinocyte and epithelial cell population (A). (B) Frequency of
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EpCAM cells in young (circles) and aged (squares) mice prior to injury and infection.
(C) Frequency of EpCAM+TLR2+ cells in young and aged mice in uninjured skin. (D)
MFI of TLR2 on EpCAM+TLR2+ cells prior to injury and infection. (E) Frequency of
EpCAM+ cells at days 1 and 3 after injury and infection. (F) Frequency of
EpCAM+TLR2+ cells following cutaneous wound infection at days 1 and 3. (G) MFI of
TLR on EpCAM+TLR2+ cells after injury and infection. Data are shown as mean ± SEM,
N=4-6 per group,*p<0.02.
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No differences in the frequency of EpCAM TLR2 CD14 cells were noted between
young and aged mice prior to injury or at day 1 post injury (Figure 29A+C). The MFI of
CD14 on TLR2+ keratinocytes was similar between young and aged uninjured mice,
however an increase in the MFI of CD14 was seen in aged animals compared to young at
1 day after injury and infection (Figure 29B+D, p<0.05). These data suggest that agedepended difference in TLR2 levels in uninjured keratinocytes could contributed to
increased susceptibility to Gram-positive infection with advanced age; however,
differences in TLR2 or CD14 on keratinocytes after injury and infection do not play a
role in altered resolution of wound infection in aged mice.
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Figure 29. Expression of CD14 on TLR2+EpCAM+ cells pre- and post-cutaneous
wound infection. Expression of CD14 and TLR 2 were determined by flow cytometry
with EpCAM+ cells being considered the keratinocyte and epithelial cell population. (A)
Frequency of CD14+ cells within the EpCAM+TLR2+ population in young (circles) and
aged (squares) mice prior to injury and infection. (B) MFI of CD14 on
EpCAM+TLR2+CD14+ cells in uninjured skin. (C) Frequency of CD14+ cells within the
EpCAM+TLR2+ population at day 1 after injury and infection. (B) MFI of CD14 on
EpCAM+TLR2+CD14+ cells at day 1 after injury and infection. Data are shown as mean
± SEM, N=4-6 per group,*p<0.02.
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Summary
Following S. aureus wound infection we observed varying degrees of induction of
mBD3, mBD14 and CRAMP in young and aged animals. Interestingly, it appears that
peak levels of these AMPs occurred between days 3 and 7. Generally, AMPs are
considered early mediators of the innate immune response to cutaneous wound injury;
however, the infection may be generating a protracted AMP response in our system. As
we did not observe consistent differences in mBD3, mBD14 or CRAMP at the mRNA
level, we cannot conclude the impact of age on these mediators. To our knowledge, the
only published study that examined the effect of age on AMP expression examined levels
of hBD2, the human homolog to mBD3, in uninjured skin from young and elderly
subjects. In this study, basal levels of hBD2 were reduced in uninjured skin from elderly
subjects as compared to young. We did not observe this same trend in uninjured murine
skin. In regards to TLR2 expression, various TLRs on differing cell types have been
showed to be affected by age. We did observe a reduction in the frequency of TLR2+
cells with age prior to injury, but following injury and infection these differences were no
longer observed. As TLR2 is important in the immediate host response to Gram-positive
infection, this basal decrease in TLR2 expression with age may enhance susceptibility to
infection associated with aging. Future work to evaluate TLR1/6 expression, the two coreceptors for TLR2, in aging skin would strengthen our knowledge regarding cutaneous
TLRs and their role in vulnerability to S. aureus infection with age. Additional work to
evaluate how aging alters AMPs following injury and infection should also be examined.

CHAPTER 6
DISCUSSION
In review, we have developed a murine model of cutaneous wound infection with
S. aureus that allows for evaluation of age-dependent differences in the immune response
to infection and tissue injury. Herein, we demonstrated that advanced aged is associated
with elevated bacterial colonization at early time points, and persistent infection out to
day 10 post wound infection. These findings parallel clinical observations in elderly
patients as they have elevated rates of S. aureus infection, which correlates with a
prolonged length of hospital stay and increased hospital costs (121, 159, 174). Other
murine models of infection, such as pneumonia, also report an increased bacterial burden
in aged animals (192). Moreover, we observed that wound closure was protracted in aged
animals. Studies in murine models of uninfected wounds report similar delays in wound
closure with advanced age (49, 63); however, the time to closure was reduced as
compared to infected wounds from our animals. Interestingly, despite the persistent
elevation in bacterial burden observed in the aged mice, the delay in wound closure was
not perturbed to a similar degree. This may be due to the relatively low inoculum used in
this study to limit septic events known to alter wound healing (176). Alternatively, the
persistence of bacteria in the wound bed may be altering other components of wound
repair such as collagen deposition which aids in restoration of the dermal matrix (63,
210). While not evaluated in this study, further work examining how bacterial infection
130
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alters the wound collagen matrix and tensile strength may help elucidate
mechanisms underlying the elevated rate of wound dehiscence in elderly patients.
An important factor in mediating the host response to infection is early
recognition of foreign pathogens by host immune cells. Following tissue injury, local and
recruited leukocytes act to detect evolutionary conserved PAMPs via pattern recognition
receptors (PRRs). TLR2 is a PRR which specifically recognizes Gram-positive bacteria
via homodimers or heterodimers with TLR1 and TLR6 (211). Activation of TLRs in
innate immune leukocytes results in NF-kB dependent production of pro-inflammatory
mediators, helping to recruit additional leukocytes and promote antigen presentation to
recruited adaptive immune cells (100, 182). Loss of TLR2, or mediators of TLR
signaling, have been associated with increased susceptibility to S. aureus infection, as
mice deficient in TLR2 or MyD88 demonstrated heightened levels of S. aureus
bacteremia (98, 181, 183, 212). Thus, we chose to evaluate TLR2 expression on
keratinocytes as well as resident and infiltrating leukocytes, as TLR2 is required to
effectively eliminate S. aureus. In uninjured skin, aged mice had a reduced frequency of
TLR2+ keratinocytes relative to young mice, though no difference in the MFI were noted.
Similarly, we observed an age-dependent decrease in the absolute number of TLR2+
resident tissue macrophages; however, no differences in expression or frequency of
TLR2+ infiltrating wound neutrophils or macrophages were observed. Together, the
reduction in the frequency of TLR2+ keratinocytes and resident macrophages may
contribute to heightened vulnerability to infection with advanced age. Other aging studies
have found variable results in regards to tissue macrophage TLR2 expression (74). While
reports demonstrate that macrophage expression of one or all TLRs are reduced with
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aging (74, 101, 192), previous studies from our own laboratory have demonstrated no
change in peritoneal or splenic macrophage TLR2 and TLR4 expression (82). In
circulating neutrophil populations, human studies suggest that expression of TLR2 and
TLR4 are unaltered with age, though membrane-associated MyD88 was decreased with
age after exogenous stimulation with LPS (45). Though not evaluated in our study, ageassociated alterations in mediators of TLR2 signaling, such as MyD88, Toll-interleukin 1
receptor domain containing adaptor protein (TIRAP) or interleukin-1 receptor-associated
kinase (IRAK), may dampen TLR2 responses in aged individuals and contribute to
delayed resolution of bacterial infection (100, 213, 214).
TLRs are also known to initiate the signaling cascade that results in elevated
AMP expression following cutaneous injury or infection. Despite reduced TLR
expression in aged animals relative to young, we did not observed a basal reduction in
AMPs levels with age. This is contrary to a study in humans in which hBD2, the homolog
to mBD3, was reduced in skin from elderly subjects as compared to young. While no
other studies have evaluated AMP expression following injury and infection in the setting
of aging, our contradictory data suggest that further work should be conducted to
elucidate if aging impacts these critical early mediators of the innate immune response.
Particular attention to be paid to the Reg family, namely Reg3, as this appears to be
most consistent in our studies and has been shown to be critical in other models of S.
aureus infection.
In addition to recognition of foreign microbes, neutrophils and macrophages that
are recruited to the site of tissue injury play a critical role in phagocytosis and killing of
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invading bacteria. Previous studies have reported that aging negatively impacts the ability
of both neutrophils and macrophages to phagocytosis pathogens (46, 50, 120, 185, 186),
though few have evaluated the phagocytic potential of leukocytes following recruitment
in response to tissue injury or infection. Following cutaneous wound injury, no agedependent differences in wound neutrophil or macrophage phagocytosis were noted.
Interestingly, studies in human neutrophils have reported an age-associated reduction in
TREM-1 mediated phagocytosis and ROS generation that mediates bactericidal activity
in human neutrophils (215). Furthermore, aging was associated with decreased FcRIII
expression in circulating human neutrophils and this correlated with reduced
phagocytosis (46). Though our observed differences in FcRIII did not contribute to
differences in phagocytosis or bactericidal activity as reported in human peripheral blood
neutrophils by Butcher et al., recent reports show that FcRII regulates FcRIII with
functional effects on phagocytosis (216, 217). Given that we did not find a functional
defect in our cell populations, we did not evaluate whether expression of FcRII, or other
phagocytic pathways such as complement-mediated phagocytosis, were altered with
advanced age. Moreover, that lack of age-related differences in neutrophil phagocytosis
is in concert with other reports in mice that do not recapitulate the phagocytosis deficits
observed in circulating human neutrophils (74). Our study extends these findings in
rodent studies to demonstrate that even after recruitment to a specific tissue
microenvironment, neutrophil phagocytosis is not impaired by advanced age.
On the other hand, human and rodent studies more definitively agree that aging
impairs macrophage phagocytosis (50, 185-187, 218), though some reports find no age-

134

dependent phagocytic differences (74, 83). DiPietro et al. examined wound macrophage
phagocytosis in young and aged mice with divergent results from those observed in this
study. Following isolation of macrophages from subcutaneous implanted PVA sponges,
phagocytosis was reduced ~40% in macrophages from aged mice relative to young mice
(50). While this study also examined the phagocytic potential of cells following
recruitment to cutaneous tissue, it did so by implementing PVA sponges to isolate
recruited macrophages (219). This environment is different than that created by the
wound milieu of an excisional wound, and may account for the observed differences. It is
also important to note that the wound cell isolation procedure and optimal conditions of
the pHrodo-S. aureus phagocytosis assay may limit observing small age-dependent
impairments of phagocytosis in either wound neutrophils or macrophages.
Most significantly, our data supports the idea that advanced age alters the
infiltration kinetics of innate immune cells following tissue injury and infection.
Alterations in infiltration of these cells can impact several facets of wound healing. First,
reduced recruitment of these phagocytes may directly contribute to heightened bacterial
levels as these infiltrating phagocytes are critical in controlling infectious spread (193).
Second, the age-dependent differences in the initial wave of neutrophil infiltration may
affect recruitment of macrophages via secreted mediators that directly interact with
macrophage chemokine receptors and the vascular endothelium (172, 220). A delay or
reduction in macrophage accumulation, or alteration in macrophage phenotype, may
further impair transition to the proliferative phase of wound healing, negatively impacting
wound closure and restoration of the dermal matrix (118, 144, 221). Moreover,
diminished macrophage function and/or numbers have been shown to delay wound
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healing and decrease wound tensile strength (145, 147). Lastly, studies in aged mice
suggest that there is a necessity for neutrophils in efficient wound healing with advanced
age (26). However, these data call into question the accepted dogma of efficient wound
healing. While macrophages are considered to be beneficial to wound healing, the role of
neutrophils in sterile wound healing is controversial. Although neutrophils are required
for eradication of invading organisms, gratuitous neutrophil accumulation can result in
excessive ROS and elastase production, in turn exacerbating tissue damage and impeding
wound healing (65, 160). Specifically, in fetal models of wound healing, there is a
paucity of neutrophil recruitment and inflammation that is correlated with reduced scar
formation (131, 222). Studies in young mice have also shown that neutrophil depletion
may accelerate aseptic wound closure (140). Despite these findings, reports in the aging
literature have demonstrated that even in the setting of sterile wound healing, ablation of
the neutrophil population delays wound closure in aged animals (49). Importantly,
increasing neutrophil numbers via i.p. administration of G-CSF enhanced rates of wound
closure in aged mice to those observed in young mice (49). In the context of an infected
wound, the necessity of neutrophil recruitment becomes increasingly paramount.
Clinically, patients with reduced neutrophil function or numbers are at a heightened risk
for chronic and repeated infections with catalase-positive bacteria, like S. aureus (43,
184, 194). Thus, the decreased absolute numbers of neutrophils and macrophages in our
model may not only contribute to bacterial colonization differences observed with age,
but may also play a role in delayed wound resolution in aged animals.
As mentioned previously, this weakened neutrophil response may alter the
kinetics and subsequent leukocyte infiltration of wound healing in aged animals.
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Recently, we reported that peripheral blood neutrophils from unmanipulated young and
aged mice have a basal hyperchemokinesis but lack directional migration ex vivo (60).
Other studies have supported that aging is correlated with neutrophil chemotatic defects
(45, 74, 200). Here, we extend these findings to show that at increasing doses of KC in
vivo, neutrophils from aged mice had a diminished migratory response to cutaneous
tissue as compared to young. While we saw blunted chemotaxis to the CXCR2 ligand
KC, we observed elevated CXCR2 expression on circulating neutrophils from aged
animals. These data suggest that despite adequate expression of CXCR2, mediators of
CXCR2 signaling may be impaired with age. For example, recruitment of -arrestin 2 to
CXCR2 has been shown to be required for CXCR2 activation (191) and has been
reported to be decreased in brain tissue of elderly humans (223). Alternatively, previous
reports have demonstrated that high levels of KC promote CXCR2 receptor
desensitization and impaired chemotaxis (25). Thus, it is plausible that the early peak in
KC levels observed in aged mice acts to attenuate neutrophil recruitment despite bacterial
infection in our aged animals. These data extend our findings in our wound infection
model, and suggest that neutrophil chemotaxis is perturbed in aged mice.
Aging studies in aseptic wound models have shown that systemic G-CSF
enhances neutrophil recruitment and reduces time to wound resolution in aged animals
(49). While the role of neutrophils in aseptic wound healing has been questioned (65,
140), patient populations that are at increased risk for infectious complications, such as
aging or immunocompromised subjects, demonstrate a necessity for neutrophil
recruitment during wound repair (Brubaker et. al 2012, manuscript submitted).
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Previously, we demonstrated that neutrophils from aged mice exhibit a migratory defect
to the murine neutrophil CXCR2 ligand KC in vitro and in vivo (60). Moreover, we have
observed neutrophil chemokine levels to be similar or elevated in wound homogenates
and enhanced expression of CXCR2 on circulating neutrophils in aged mice (Brubaker et.
al 2012, manuscript submitted). Together, these data suggest that age-associated
alterations in the downstream CXCR2 signaling cascade may contribute to reduced
neutrophil recruitment. G-CSF has been shown to mediate neutrophil migration to
macrophage-inflammatory protein-2 (MIP-2), another CXCR2 ligand, via STAT3
mediated induction of CXCR2 expression and regulation of CXCR2 signaling (224).
Additionally, in vivo G-CSF has been shown to restore ex vivo neutrophil chemotaxis in
aged rats (200) and following systemic trauma (225). Given these data, it is reasonable to
suggest that enhancing neutrophil recruitment in aged mice may reduce bacterial
colonization and wound closure. In the study by Nishio et al., G-CSF may not only be
enhancing circulating neutrophil numbers but may aid in overcoming an age-related
migratory defect by enhancing CXCR2 mediated signaling. Based on those data, we
attempted to modulated neutrophil recruitment in aged mice via local, s.c. G-CSF
administration. We demonstrated a beneficial effect of G-CSF treatment on resolution of
infection and wound healing in aged mice following S. aureus wound infection. These
reductions in our primary outcomes were associated with enhanced neutrophil
recruitment to the wound site in aged mice following treatment with G-CSF at days 3 and
7. G-CSF treatment did not affect wound macrophage or T cell numbers at days 3 and 7
as compared to saline treated young and aged mice. While the precise mechanism
remains unclear, we postulate that restoration of neutrophil recruitment in our model may
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be through a G-CSF mediated restitution of CXCR2-directed signaling and chemotaxis in
aged mice (Figure 30). G-CSF may act to stabilize CXCR2 signaling in aged animals by
enhancing downstream factors such as STAT3 and Rap1 (26, 28, 224). Together this
would promote upregulation and clustering of integrins, including LFA-1 and VLA-4,
which interact with ICAM-1 and VCAM-1, respectively, on activated endothelium (26).
Potentially, increased interactions between these molecules could enhance neutrophil
firm adhesion and diapedesis, allowing increased neutrophil recruitment to sites of injury
and infection in aged animals. To our knowledge, this is the first study to demonstrate the
differential effects of G-CSF as a therapeutic modality in the setting of wound infection
with advanced aged. Future work needs to be conducted to elucidate the precise
mechanism by with G-CSF exerts these age-dependent effects.
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Figure 30. Proposed mechanism: G-CSF treatment restores age-dependent
differences in neutrophil recruitment by enhancing signaling involved in neutrophil
chemotaxis. We postulate that G-CSF acts to stabilize signaling downstream of CXCR2.
Potentially, G-CSF may act to enhance STAT3 or Rap1 activation, increasing
upregulation and clustering of integrins that facilitate firm adhesion to the activated
endothelium. Conceptually, this would promote elevated adhesion and transmigration of
neutrophils to the site of injury and infection. Further studies are needed to determine if
this is the mechanism by which G-CSF exerts age-dependent effects in our model.
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G-CSF is a known modulator of granulopoiesis and hematopoietic stem cell
mobilization as well as a regulator of neutrophil bone marrow emigration, survival,
chemotaxis and phagocytosis (226-229). Currently, G-CSF (Filagrastim/PEGFilagrastim) is indicated for patients with congenital or iatrogenic neutropenias (230) and
for donors prior to hematopoietic stem cell transplantation (231). Pre-clinical and clinical
trials are underway to investigate the therapeutic potential of G-CSF in amyotrophic
lateral sclerosis (232, 233), acute liver failure/alcoholic hepatitis (234), myocardial
infarction (235), peripheral arterial disease (236) and diabetic foot infections (237, 238).
Alongside our study, these reports provide novel indications for the expanded use of GCSF as therapeutic interventions.
The studies using G-CSF in the setting of diabetic wound infection provide an
interesting point of comparison to the data presented in this manuscript. Cruiciana et al.
reviewed five randomized controlled trials with a total of 167 patients that added G-CSF
to treatment regimens for patients with diabetic foot infections. Though one study
reported a shorter time to resolution of infection and intravenous antibiotic use (239), the
meta-analysis revealed that addition of G-CSF did not decrease the risk of infectious
complications or enhance wound closure, but it did reduce the relative risk of lower limb
surgical interventions and the hospital length of stay (237). Similar to advanced aged,
neutrophil dysfunction and elevated risk of S. aureus infection are associated with
diabetes (240). However, the studies above do not suggest a strong therapeutic benefit for
G-CSF in diabetic patients. Diabetes is also associated with peripheral arterial disease
(PAD) that may inhibit additional facets of wound healing which may not be modulated
by G-CSF. Though not evaluated in our studies, aging is associated with alterations in
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angiogenesis of local vasculature following cutaneous wound injury (63); however, this
differs from the more extensive vascular compromise associated with diabetic PAD.
Moreover, studies in db/db mouse models have actually demonstrated elevated neutrophil
recruitment to sites of S. aureus infection in db/db mice (240). This is in contrast to our
model, in which reduced neutrophil accumulation in aged mice was associated with
delayed bacterial clearance and wound closure.
Other studies do support a therapeutic benefit for G-CSF in prevention of
infectious complications (241, 242). In patients undergoing esophagectomy for
esophageal cancer, perioperative, s.c. G-CSF improved neutrophil effector functions and
elevated circulating leukocyte counts (241). Infection rates and postoperative death were
also reduced in the treatment groups as compared to historical controls (241). In a case
report, daily G-CSF treatment in a neutropenic patient that developed a non-healing
pharyngocutaneous fistula following radical laryngectomy promoted closure of the fistula
where previous aggressive wound therapy failed (242). These papers support the use of
G-CSF in infectious wound care settings in neutropenic patients. While no peripheral
neutropenia was noted in our aged animals prior to G-CSF treatment, we did observe a
local reduction in neutrophil numbers at the wound infection site in saline-treated aged
mice that was restored following G-CSF administration.
As bacterial strains, in particular S. aureus, continually evade our current
antibiotic treatments, understanding how advanced age impairs the host immune response
may allow us to target immunomodulatory mechanisms that will improve outcomes
following cutaneous wound injury in elderly patients. While future work needs to be
conducted to elucidate the mechanism by which G-CSF exerts these age-dependent
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effects, our data highlights a putative indication for G-CSF treatment within the wound
care setting in the elderly patient population as well as patients with local or systemic
neutropenia.
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